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DEFINITIONS AND KEY TERMS 
 
 
Microbicides: A generic term for agents that can block, kill, or immobilize dangerous pathogens. These 
products, which are still under development, may offer the possibility for women (and men) to protect 
themselves from vaginal and rectal transmission of HIV and, potentially, other STIs. Microbicides will be 
used intravaginally and may be available in several forms (e.g., as a gel, suppository or film. It is also 
possible that they will be used rectally. 
 
Partial Effectiveness: Refers to estimates of effectiveness of first-generation products ranging from 40 
to 70 percent. It is anticipated that the effectiveness of initial microbicide products will be considerably 
lower than the effectiveness of condoms with perfect use (98%).  
 
Prevention Equation: Refers to the notion that a lower-efficacy product used consistently could have a 
greater impact on reducing infection at the individual and population level than a higher-efficacy product 
that is used less consistently. One of the premises for microbicide use has been that condoms, while 
highly effective when used “perfectly,” are often used incorrectly or not at all because they can be 
difficult to use and are perceived as reducing sexual pleasure. Microbicides may be used more 
consistently if they are easier to use, perceived as interfering less with sexual pleasure, and their use can 
be initiated by women.  
 
Condom Substitution/Migration: Refers to the concern that people who successfully use condoms 
might use microbicides instead, which could lower their overall level of protection.   
 
Hierarchy of Methods: Refers to the offer of a range of methods by level of effectiveness, the risks 
and benefits offered by each method clearly identified. For example, if partially-effective microbicides 
were introduced into an HIV prevention program, a message about prevention technologies would be: 
“Condoms and microbicides used together offer the best protection against HIV. If you can’t use both 
products, you should use male latex condoms every time you have sex. If you can’t use male condoms, 
female condoms offer the next-best protection. If you can’t use condoms, microbicides used alone could 
significantly reduce your risk of HIV infection.”   
 
Method Mix: Refers to the range of HIV/STI and pregnancy prevention methods or products available 
within a given program or service delivery setting.  
 
Dual Protection: Refers to the prevention of both pregnancy and HIV/STIs through any of the 
following: use of a single product that prevents both (e.g., condoms); use of two methods (dual-method 
use, one for contraception and one for disease prevention); mutual monogamy with an uninfected partner 
using a contraceptive method; the avoidance of risky sex; or a range of other risk-reduction strategies.  
Although this term sometimes refers to protection against both HIV and other STIs, it is not used that way 
in this report. 
 
Dual Methods: Refers to the use of two methods simultaneously (e.g. condoms and pills, or condoms 
and microbicides) to prevent HIV and pregnancy or to increase the effectiveness of an HIV prevention or 
pregnancy prevention method. 
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With recently accelerated support for the development of microbicides to prevent HIV transmission and 
the urgency of the global AIDS epidemic, it is important to begin to identify strategies for introducing a 
microbicide once it is proven safe and effective and is approved for use. This report presents results from 
a qualitative study that explored a range of issues likely to influence microbicide introduction—positively 
or negatively—at three levels: community, health service, and policy. The study identified critical issues 
to be addressed in building support for microbicides and facilitating smooth introduction.  
 
Historically, technological innovations have had varying degrees of success in introduction; some have 
encountered significant obstacles that might have been avoided with more careful preparation. It is 
critically important to understand gender-related, social, economic, cultural, and structural contexts before 
any new innovation is introduced. This research aims to inform microbicide introduction strategies in an 
effort to avoid the delays and false starts that have hindered the introduction of new health technologies in 
the past.  
 
The introduction of microbicides is likely to be complex for a number of contextual and product-related 
reasons. First, microbicides, especially the first generation of microbicidal products, are likely to be 
partially effective, with lower effectiveness than condoms in preventing HIV transmission. Second, 
microbicides will be “user-controlled” vaginal products that require acknowledgement and discussion of 
sexuality and sexual practices, issues that policy makers, providers, and users can find difficult. Finally, 
by potentially providing women with more power and control over their sexual lives, microbicides may 
challenge traditional gender norms. Given this range of complex issues, targeted social-science research 
into the beliefs and attitudes that are likely to affect understanding, acceptance, and use could greatly 
facilitate the introduction of this new technology. Such research can be used for informing policy, 
identifying necessary adjustments in the service delivery context, and guiding message development and 
product imaging for communities and users. 
 
The study was conducted between September 2002 and September 2003 in Langa, a peri-urban site in the 
Western Cape Province of South Africa, and at national and provincial levels. Through in-depth 
interviews and focus group discussions, this study explored and identified issues that could facilitate or 
undermine access to and use of microbicides. The study included a range of respondents from the three 
levels of inquiry. Respondents included community members, health care providers and managers, 
provincial- and national-level government officials, and representatives from national and provincial 





The need for microbicides 
 
Respondents at all three levels expressed support for microbicide introduction. The severe effect of the 
AIDS epidemic on people’s everyday lives and the urgent and desperate need for new approaches to help 
curtail the spread of HIV was the most powerful argument for microbicides to emerge from the data.  
 
The respondents conveyed an understanding and acceptance of the reality of women’s social vulnerability 
to HIV infection and the limits on women’s ability to protect themselves, including the need for female-
initiated prevention options due to widespread resistance to male condom use. Since microbicides are 
expected to be mostly female-initiated and controlled, participants felt that the products could provide an 
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important option in giving women the ability to protect themselves with or without their partners’ 
support.  
 
The “prevention equation”—the idea that a lower-efficacy product, like microbicides, used consistently 
could provide overall protection at the individual and population level better than a higher-efficacy 
product, like condoms, used less consistently—generated little reaction when raised by the interviewers. It 
is not certain whether this was due to the concept being unclear, or because respondents did not need 




Respondents at all levels were concerned about the partial effectiveness of the first generation of 
microbicides, presented as ranging from 40–70%. Despite apprehensions among a few providers and 
policy-makers about promoting a partially-effective method, most saw it as a trade-off to the high need 
and demand for such a product. They supported its introduction, pointing out that no method is “one 
hundred percent” effective, including condoms with typical use. Additionally, many providers and policy 
makers pointed out that the numerous barriers to condom use underscore the need for more acceptable 
prevention alternatives such as microbicides. The concept of a “hierarchy of methods” naturally emerged 
form the discussions. Some felt that microbicides should be positioned alongside male and female 
condoms either as a dual method or as stand-alone products to reduce risk where other, more effective 
prevention options are not feasible. The severity of the situation made women feel that it was preferable 
to take some action rather than to do nothing, even if microbicides were not 100 percent effective.  
 
Covert or overt use 
 
Women’s lack of power in sexual relationships was cited as both a barrier and an incentive to microbicide 
use. Both women and men strongly recommended partner involvement and open communication about 
microbicide use, and many believed that such communication would be feasible. Other participants, 
however, felt that in the context of certain relationships, covert use would be a necessary alternative 
where there was a lack of trust between partners, where women lacked the power to negotiate the 
method’s use, or where they feared repercussions, including violence, of raising  microbicide use with 
partners. Community members, service providers, and policy makers alike questioned women’s ability to 
negotiate microbicide use and said that even covert use might be difficult or could result in negative 




Opinions varied about the potential impact of microbicides on condom use, specifically whether people 
who successfully use condoms would be likely to use microbicides instead. Some policy-level 
respondents worried that microbicide introduction could undermine condom use, particularly among 
adolescents. Some male—and female—focus group participants indicated that they might, indeed, stop 
using condoms in favor of microbicides. In contrast, many respondents recognized that among many 
groups consistent condom use remains low, and felt that the introduction of microbicides would not 
decrease condom use. Instead, they felt that microbicides could potentially provide an important 
alternative for those who would not or could not use condoms.   
 
Rape and unplanned sex 
 
Respondents described several situations requiring a long-acting product that women could insert before 
leaving the house as a routine practice in case something unexpected or unplanned happened that would 
expose them to risk. Concerns about sexual violence were expressed strongly and discussed at length. In 
addition to their own fears, participants in community focus group discussions frequently raised the 
possibility of young children being raped. Respondents also felt microbicides would be useful when a 
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woman had unplanned, but consensual, sex, or for protection in case a man attempted to infect them 
intentionally. People assumed that the product would be long-acting and convenient enough to be used 
daily. None of these possibilities was asked about directly or probed for; participants spontaneously raised 
them in many focus groups and interviews, indicating that this could be a potentially important role for 
microbicides.     
 
“Wetness” and lubrication 
 
Concerns emerged among respondents at all levels about “wetness,” pertaining to the added moisture that 
a microbicide formulated as a gel or cream could provide during sexual intercourse. Wetness was 
discussed, for the most part, from three perspectives: a) a woman’s vaginal wetness implying infidelity 
(i.e. she had been with another man); b) the preference of men for a “not wet” or “dry” vagina for 
increased sexual pleasure; or c) the association of wetness with sexually transmitted infections (STIs). 
Men were concerned that it would be difficult to distinguish whether a woman was wet due to the 
microbicide or because she had sex previously with another man, and women were anxious about being 
accused of infidelity. Many referred to men’s preferences for the vagina to be dry or “not wet” (although 
this was not associated with the use of drying agents), indicating that wetness associated with 
microbicides could be perceived as negatively affecting sexual pleasure. 
 
Intravaginal product use 
 
Participants expressed wide-ranging and contradictory views about women’s experience and comfort with 
the use of vaginal products. Women in focus groups said they were familiar and comfortable with using 
vaginal products and were already using tampons and “vaginal creams for thrush.” Providers supported 
this view, although policy-level respondents gave mixed views, some expressing concern that women 




The aesthetic and physical characteristics of microbicides also were viewed as important intrinsic factors 
that could hinder or facilitate microbicide use. In terms of physical properties of the product itself, 
characteristics of concern included smell, messiness, stability at different temperatures without 
refrigeration, duration of effectiveness, and how well the product would adhere in relation to bodily 
functions (e.g., whether the microbicide would be washed away with urination). Respondents expressed 
discomfort with aspects of the sample applicator shown, and suggested alternative product forms.  
 
Respondents at various levels of inquiry differed in their views on the preferred scope of protection 
against HIV, other STIs, and pregnancy. Women tended to prefer microbicides that would not prevent 
pregnancy, while more men favored products that also were contraceptives, although many presented 
contrasting views. Providers were keen on offering microbicides that could prevent a range of STIs in 
addition to HIV and were less interested in the product’s contraceptive properties, while several policy 
makers felt that a microbicide with dual protection (contraceptive and STI prevention) could facilitate use 
and be a beneficial addition to family planning programs. 
 
Potential microbicide users 
 
Respondents thought that a wide range of people, including very young girls, youth, married and 
unmarried women, older women, and men, could potentially use microbicides. Health care providers  
were generally more comfortable categorizing appropriate microbicide user groups according to risk, 
particularly those with a history of STIs, HIV-positive individuals, sex workers, and those unable to 
negotiate condom use. Community participants and some providers suggested that youth should be the 
main users and beneficiaries of a possible future microbicide, because they were the most sexually active, 
did not use condoms, and were the most vulnerable to unplanned, unprotected, and coercive sex.   
 Paving the Path: Preparing for Microbicide Introduction ! 4 ! Qualitative Study Report  
However, some policy makers expressed reservations about targeting youth, citing in particular recent 
gains in condom use among this group. 
 
Need for information 
 
Policy makers, providers, and community participants all stated that they would need information about 
effectiveness, efficacy, safety, side effects, and contraindications before they would recommend 
microbicides to clients or support their introduction. Given that the first microbicides will not provide 
complete protection, both national and provincial level policy makers pointed out that clients must be 
fully aware of the implications of partial effectiveness. They emphasized a desire to have access to 
evidence from both animal and human clinical studies to determine whether microbicides were in fact 
safe and effective. Respondents’ understanding of concepts such as safety, efficacy, and partial 
effectiveness were often erroneous; some policy makers highlighted the need to further examine the way 
in which information about these key concepts should be conveyed to potential users, policy makers, and 
providers, stressing the need for simple yet comprehensive information to facilitate informed choice.  
 
Distribution and marketing 
 
Participants across all three levels of inquiry also felt that microbicides should be distributed widely—not 
only in health clinics, such as family planning, well-baby, maternal health, and VCT centers, but also in 
places where women congregate and locations that are easily accessible in the community: chemists; 
supermarkets and shops where herbal medicines are obtained; local informal shops and bars; and 
community-based organizations. Despite a desire for widespread access, many respondents at all levels, 
concerned about safety and partial effectiveness, hesitated to endorse distribution of these products in 
venues where personal counseling is not available or quality control would be difficult to ensure. In 
community focus groups, men and women of all ages and socio-economic groups stressed the need for 
media campaigns and for community-based sources of information to be available at such places as 
churches, schools, libraries, and other community organizations.  
 
Sustainability of supply and cost 
 
Several policy-level respondents warned about the problems in creating demand for the product at the 
community level before supplies are sustainable. Citing some experience with the female condom, they 
underscored that a reliable and affordable supply needs to be in place before widespread marketing of 
microbicides begins. To address these concerns, and to allow users to become familiar with the products, 
some suggested a gradual introduction strategy. National and provincial policy makers, key policy 
informants, and providers all stressed that microbicides should be accessible to clients and provided at 
low cost or free. Some community and policy-level respondents supported the assertion of social 
marketers that products distributed in the public sector or free of charge are seen as inferior to other 
methods or products. Finally, a number of policy makers expressed concern about the cost to the health 
system, the lack of resources throughout all levels of the health system, and the difficult decisions that 





A number of key results from this study—in areas such as product characteristics, condoms and condom 
substitution, partner involvement versus covert use, distribution strategies, and lubrication (“wetness”)—
echo and expand upon findings of previous social science research and programmatic experience. 
However, several somewhat unexpected issues emerged quite strongly, such as the widespread 
understanding of women’s vulnerability and their need for alternatives like microbicides, and the broad 
assumptions about microbicide use for protection in case of unplanned sex or rape. Several of these 
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themes have direct implications for policy or further research related to product development and 
introduction.  
 
Support for microbicides 
 
Consistent with the growing recognition of the need for microbicides, respondents across the range of 
categories expressed strong support for product development and introduction. This interest derived from 
several related underlying issues that were described frankly and eloquently. First, participants exhibited 
widespread understanding and recognition of women’s vulnerability to HIV infection. Many spoke 
openly—and spontaneously—about the underlying social, economic, and political factors that contribute 
to women’s lack of control over sexual relations. Given the devastating impact of the HIV/AIDS 
epidemic in this setting, there was a real sense of desperation among community participants, providers, 
and policy makers for something that could help prevent HIV infection. Second, while respondents in all 
groups felt strongly that condoms must be promoted, there was widespread recognition of the limitations 
of condoms and their use. There was a strong sense that additional technologies and approaches are 
urgently needed, especially those that women can initiate, and a real frustration at the relatively long 
timeframe before an effective microbicide could potentially be made available. 
 
Despite some concerns, the need and potential for microbicides resonated strongly with those interviewed 
for this study. This may be attributable largely to the impact of the HIV/AIDS epidemic and the vigorous 
public discourse on AIDS in South Africa; strategies for developing support for microbicides will clearly 
need to be tailored to other contexts. Even with the significant support among those interviewed for this 
study, participants expressed a number of concerns and uncertainties about microbicides, and an 
understandable need to know more about a specific product before they would approve, recommend, or 
use it. Therefore, while there seemed to be widespread general support for a product like a microbicide, a 
more specific case will need to be built based on the evidence from research and characteristics of a 
particular product.   
 
Implications of introducing a partially effective product  
 
As expected, the issue of partial effectiveness emerged as a major concern, particularly among providers 
and policy makers. Discussion underscored the challenges of accurately conveying complex messages 
about risk reduction and the options presented by a partially effective product. Initially, respondents 
across all three categories expressed some unease about the implications of introducing microbicides as  
“stand-alone” products, given that they will be less effective than condoms. Many were more comfortable 
with microbicides as a complement or addition to existing prevention options, and with including them as 
part of a hierarchy or method mix so that people would be able to choose from more options. A striking 
element of these interviews is how providers’ and policy makers’ concerns about partial effectiveness 
evolved from initial apprehension about practical and ethical implications to a more positive and 
affirmative view of the role microbicides could play in reducing individual risk and population-based 
incidence. This underscores some of the complexities of resistance to microbicides and suggests that 




Policy and provider-level respondents expressed some concern about the possibility that introducing 
microbicides may lead people to switch from condoms to microbicides, undermining condom promotion 
and use. Some community members confirmed this possibility, indicating that they would welcome the 
availability of microbicides primarily because they would provide an alternative to condoms.  
Providers and policy makers reflexively positioned condoms as the “gold standard,” although on further 
reflection most acknowledged the condom’s limitations and that actual use among many groups is low.  
This suggests the importance of developing policy approaches and messages for introducing microbicides 
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that accurately reflect actual condom use and the impact of condoms in HIV risk-reduction, rather than a 
theoretical ideal. In addition, while acknowledging that condoms are unpopular, participants rarely 
discussed perceptions or assumptions about the particular circumstances and types of relationships in 
which condoms or microbicides would be used.   
 
Given growing understanding about how relationships and other circumstances influence condom use, it 
would be useful to explicitly explore these themes with respect to microbicides. Finally, concerns about 
condom substitution will likely shift along with any changes in condom use that may occur: if condom 
use increases before microbicides are introduced, condom substitution may become more of a concern.  
Given the long timeframe for microbicide development and introduction, this issue will need to be 
continually revisited in light of any changes in patterns of condom use. 
 
Rape and unplanned consensual sex  
 
One of the primary unexpected findings was the degree to which respondents across levels—especially 
community members—assumed that an important application for microbicides would be use by women to 
provide protection in case of rape. Rape is widespread in South Africa and has been extensively discussed 
and debated in the public arena, contributing to an acute awareness of the problem and a perception that it 
constitutes an immediate risk in women’s daily lives. Women also discussed the utility of microbicides in 
the case of unplanned consensual sex. Both of these uses imply an assumption that women would be able 
to apply a microbicide as part of a daily routine. This would necessitate that a microbicide have a 
relatively long duration of action, and that it would be both affordable and convenient enough to be used 
daily. This has important implications for microbicide development and for how microbicides could be 
introduced or marketed. 
  
Wetness, lubrication, and intravaginal practices 
 
The issue of “wetness” resonated strongly with study participants as a serious concern. It has been an 
ongoing concern in the microbicide field that the lubricating properties of current gel formulations could 
compromise acceptability and widespread use of microbicides. Respondents across categories had 
different perceptions about how important added lubrication might be in hampering microbicide 
acceptability and use. Consistent with recent reviews of this issue, the extensive discussions and wide-
ranging interpretations of lubrication in this study underscore the need to examine the actual meanings 
associated with wetness and lubrication in different settings, rather than relying on assumptions about 
practices and preferences. Similarly, the different perceptions of policy makers and community members 
with regard to women’s comfort with intravaginal product use point to the importance of examining 
actual experience rather than assumptions. Beliefs and assertions by policy makers or providers that 
“women won’t use them [microbicides]” because they are inserted vaginally could erroneously inhibit 
support for microbicides, even in settings where women regularly use vaginal products.  
 
Positioning and distribution strategies 
 
Findings from this study suggest that microbicides could be positioned for a wide range of potential users.  
While in other settings people often assume that “high risk groups,” particularly sex workers, would be 
the most likely and appropriate users, respondents in this study suggested a much wider range, including 
children (in the case of rape) and “older” married women. It was widely assumed that younger, unmarried 
women, including youth, would be important users of microbicides; however, while this assumption was 
strongly supported by providers and community members, policy makers were less supportive of 
targeting youth due to concerns about potentially undermining recent gains in condom use and thereby 
increasing risk. There was strikingly little stigma associated with microbicides or the people who might 
use them, and a real sense that microbicides would be “mainstream” products. 
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Suggested distribution strategies underscored the tension between making microbicides widely available 
in a range of clinical and non-clinical outlets and the challenges of conveying complex messages about 
risk reduction and partial effectiveness, which imply the need to control distribution to assure counseling 
and fully informed choice. Community members suggested a wide range of potential distribution points 
and strategies and cautioned against “medicalization” of the product. On the other hand, given that the 
first microbicides might be only partially effective, policy makers, providers, and community members 
hesitated to endorse widespread distribution without adequate counseling or information. There was some 
support for a compromise approach where products could be introduced first through a more formal 
clinical setting; then, once the public is familiar with the products’ attributes and has some experience 
using them, more widespread availability could be phased in over time. In general, there was a strong 
sense that the best approach to positioning and marketing microbicides would be to build on strong, 
affirmative messages that would associate the product with a healthy, dynamic, positive, and modern 





The recommendations presented below have been selected to highlight some of the less expected findings 
and areas requiring careful analysis in other geographical, social, and epidemiological contexts.  
 
Making the case for microbicides 
 
" “Make the case” for microbicides based on specific context: Further research in other 
geographical and epidemiological settings is needed to determine the best approach to “making 
the case” for microbicides. In this study, there appeared to be little need to convince people of the 
necessity for a product like microbicides. The broad recognition of the need for microbicides 
found in this study may not carry over to other settings where such issues are more hushed or 
stigmatized, where women’s vulnerability is not as well recognized, where public discourse about 
AIDS and microbicides is less evident, and where cultural differences place greater restrictions on 
open discussion of sexual behaviors and practices.  
 
" Communicate the rationale: Efforts to evaluate the acceptability of microbicides at the provider 
and policy levels will require dialogue and probing beyond immediate responses. Likewise, 
communicating the rationale behind microbicides will require more than simple messages. 
Despite broad support for microbicide introduction found in this study, initial responses were 
more mixed and muted. Opinions changed when people talked through the issues to arrive at their 
own conclusions, a finding that points to the value of qualitative research for in-depth exploration 
of issues. These findings also suggest the need for advocacy and introduction strategies to assure 
adequate dialogue. 
 
" Understand how the “prevention equation” can be used: Further investigation will be needed 
to determine how the prevention equation is understood, and whether and how it could help to 
make the case for microbicides. It did not appear to be particularly important in convincing policy 
makers of the value of even partially effective microbicides in this context. However, this may 
differ in settings where the AIDS epidemic has not had as substantial an impact, and were 
microbicides may not be as readily accepted and supported.  
 
" Use information on intravaginal practices to counter erroneous assumptions: Assertions that 
women will not use intravaginal products may not hold true, as shown in this study. Introduction 
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and advocacy efforts may benefit from local data about actual use of intravaginal products to 
counter erroneous assertions that could undermine introduction efforts.  
 
Developing introduction strategies 
 
" Balance broad access with the need for counseling and informed choice: The possibility of 
using distribution channels outside of the health sector, or outside of clinical service delivery, 
should be further explored in preparing for introduction. It will be important to balance interest in 
assuring broad access with the need for careful counseling, particularly given partial effectiveness 
and the attendant hierarchical approach.  
 
" Address provider information and training needs: To assure support from providers and 
providers’ participation in introducing microbicides, strategies must pay careful attention to 
providers’ information and training needs. Providers, who could be pivotal in influencing 
microbicide use, will need in-depth information on issues such as side effects and results of 
clinical studies, and training in order to feel comfortable recommending microbicides. They also 
will need support in formulating comprehensive yet simple counseling messages that allow 
clients to make informed choices. Although most providers in this study would likely support 
microbicides given adequate information, providers in other contexts may not be as receptive.      
 
" Market for use with or without a partner’s knowledge: Marketing and introduction strategies 
should take into account the need for both covert and overt use of microbicides. This study 
clearly demonstrated the desire by both women and men to communicate about microbicide use; 
however, respondents also recognized that many circumstances would require use without a 
partner’s knowledge, and they noted the benefits of having a method that could not be detected.   
 
" Consider youth as a potential target group for microbicides: Youth need to be seriously 
considered in clinical studies, introduction strategies, and further research as a potential user 
group for microbicides. Young people were spontaneously and consistently identified by various 
study participants as among the primary potential users of microbicides. The results point to the 
need to develop strategies that actively facilitate access and use by youth in South Africa while 
addressing some policy-makers’ concerns about targeting youth. In different settings, even with 
similar needs, young people’s access to sexual and reproductive health services may be more 
constrained, and receptivity to them as a user group may differ.   
 
" Ensure a balance of supply and demand: Reliable supply and delivery systems must be in 
place before demand is created for a product. This is particularly important during the critical and 
sensitive introduction and scale-up stages. Although in this study only a few respondents reflected 
a broad distrust of “the system,” introducing a product and failing to meet demand could 
potentially exacerbate such distrust, which could slow or halt introduction efforts.  
 
" Enlist multisectoral support for introduction: Given the complicated nature of microbicides 
and concerns around partial effectiveness, enlisting the support of broad segments of society is 
likely to be critical. Several policy makers, policy influentials, and community key informants in 
this study stressed the importance of enlisting the support of individuals and organizations inside 
and outside of the health sector. The support of community groups, churches, labor unions, and 
others may be essential to “counter the fear of the unknown” that may come with the introduction 
of a new product.  
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" Address diverse needs: It will be important to determine the possibilities for different 
microbicide products to meet varying needs and to continually reassess these as new methods 
with different characteristics become available. This research suggests interest in both free and 
low-cost products, the potential for use with or without a partner’s knowledge, and appeal to 
different user groups, including married or unmarried people, youth, and sex workers. It also 
suggests the need for use under varying circumstances, such as daily routine use in case of 
unanticipated sex, and use in specific situations or with specific partners. Product characteristics 
such as contraceptive properties and formulations (gel, suppository, film, etc) could affect the 




" Use qualitative research to understand the complexities of perceptions about microbicides, 
and to allow new ideas to emerge: Further targeted, qualitative research designed to allow 
emergence of new ideas would be valuable to inform introduction strategies and to better 
understand the potential facilitating factors and barriers to microbicide use. In this research, effort 
was made to identify critical issues up-front based on previous research, review of the literature, 
and evolving discourse in the microbicide field. Nevertheless, several important issues that had 
not been anticipated emerged from the research. For example, the prevalent notion of routine 
microbicide use as a response to the threat of rape or sexual coercion, the notion that microbicides 
would be useful to put in “before you go out” in case of unplanned sex, and the importance of 
youth as a primary user group all emerged quite strongly from the data.  
 
" Understand the meanings and implications of “wetness”: Further research is needed to better 
understand how notions of vaginal “wetness” may impact the introduction of microbicides in this 
and other settings. “Wetness” emerged as a major concern, though respondents ascribed a variety 
of meanings to it (“wetness” signifies infidelity, reduces sexual pleasure, is symptomatic of an 
STI) and the research did not affirm a prevailing belief and concern among prevention and 
microbicide advocates that “dry sex” is idealized. Little is known about whether these same 
concerns would apply in other settings, and their implications for product development, 
marketing strategies, and education and counseling approaches. 
 
" Investigate potential stigma associated with microbicides: The implications of stigma for 
microbicide introduction strategies in diverse settings is particularly important in considering 
distribution channels and marketing efforts. Although stigma against the product itself or against 
those who might need the product did not emerge in this research as a major issue, this may be 
quite different in other settings.   
 
" Develop and test approaches to explaining partial effectiveness: Further research will be 
needed to determine approaches to explaining the meaning and implications of partial 
effectiveness. Partial effectiveness was clearly a major concern among all groups interviewed, 
and participants in this study varied widely in their understanding of the concept. Determining 
approaches to explaining concepts such as partial effectiveness for different audiences will be 
useful to ongoing research, advocacy, and ultimately, introduction efforts. 
 
" Investigate the effectiveness and implications of microbicide use by HIV+ women: Given the 
growing population of HIV+ people in South Africa and elsewhere, further consideration needs to 
be given to the reproductive and other health needs of this group. This is particularly important in 
the context of more widespread availability of anti-retroviral treatment in South Africa and 
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elsewhere and in the light of possible interactions between other contraceptive methods such as 
hormonal contraceptives for women, for example. 
 
The challenges facing microbicide introduction are complex, as the findings of this study demonstrate, 
and respondent views have clearly been influenced by the sense of urgency and desperation in face of the 
devastating impact of the HIV/AIDS epidemic in South Africa. This study aimed to gain some 
understanding of the barriers and facilitating factors to microbicide introduction in the South African 
context. For some issues, we have a better understanding of how they are perceived, and the nature of 
concerns around them. Other issues have newly emerged from this research. Many will require further 
investigation and consideration in other epidemiological and socio-cultural settings. Some will prove to 
be more broadly applicable, and others are more specific to the local or national context. Successful and 








With recently accelerated support for the development of microbicides to prevent HIV, and the urgency of 
the AIDS epidemic, it is important to identify strategies for introducing a microbicide once it is approved. 
This report presents results from a qualitative study designed to inform microbicide introduction 
strategies. The study focuses on a range of issues likely to influence microbicide introduction—positively 
or negatively—at three levels: community, health service delivery, and policy. It identifies critical issues 
to be addressed in building support for microbicides and developing strategies for their introduction. The 
results are intended to help define additional work needed related to policy, advocacy, and further 
research.  
 
Why explore introduction issues in advance? 
 
Historically, technological innovations have had varying degrees of success in introduction; some have 
encountered significant obstacles that may have been avoided with more careful preparation. Experience 
with introducing new health technologies has repeatedly demonstrated the importance of designing 
approaches to introduction that anticipate potential barriers and ensure a health service delivery and 
policy environment conducive to introduction.* Such efforts include advocacy and public education to 
ensure accurate information about attributes and side effects, and to dispel myths or misconceptions. As 
such, it is critically important to understand the gender-related, social, economic, cultural, and structural 
contexts before innovations are introduced. This research aims to inform microbicide introduction 
strategies in an effort to avoid the delays and false starts that may slow the introduction of new health 
technologies and innovations. This study identifies issues that will require more in-depth analysis and 
action, and also suggests the degree of effort that will be required to prepare for introduction and the 
timing of additional research efforts and actions relative to the expected timeline for product availability.   
 
The introduction of microbicides is likely to be complex for a number of contextual and product-related 
reasons. First, microbicides, especially the first generation of products, are likely to be partially effective. 
Yet, in situations where condoms are not used, microbicides may offer an important alternative for a 
woman to protect herself from HIV infection. It is also important that policy makers in particular 
understand that a method less effective than condoms, if used more consistently, could have an even 
greater impact on reducing HIV transmission for individuals and communities. Second, microbicides will 
be a “user-controlled” vaginal product that requires acknowledgement and discussion of sexuality and 
sexual practices, issues that policy makers, providers, and end-users can find difficult. Finally, by 
potentially providing women with more power and control over their sexual lives, microbicides may 
challenge traditional gender norms.  
 
Given this range of complex issues, targeted social science research into the beliefs and attitudes that are 
likely to affect understanding, acceptance, access, and use could greatly facilitate the introduction of this 
new technology. Such research may be useful in informing policy by identifying necessary adjustments in 
the service delivery context, and guiding message development and product imaging for communities and 
potential users. 
 
                                                 
* A review of the literature on introduction of other health technologies and products with an analysis of the lessons 
learned as applied to microbicides is provided in a separate document. 
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The study was a collaboration among researchers from EngenderHealth, The Population Council, the 
International Partnership for Microbicides (IPM), and the University of Cape Town Women’s Health 
Research Unit (UCT/WHRU). A Local Advisory Group (LAG), which included stakeholders drawn from 
the community, public health practitioners, and policy makers, supported and informed the research 
design and implementation.  
 
 




A.    STUDY SITE 
 
This study was conducted in South Africa, largely in the community of Langa, near Cape Town, and also 
included national- and provincial-level respondents. South Africa was selected for this study because it 
has among the world’s highest rates of HIV infection, with more than 20 percent of the population 
infected. As in the rest of Africa, women are at high risk of HIV infection due to the confluence of 
physiological, socio-cultural, economic, and political factors. It is also the site for a number of clinical 
trials and acceptability studies of microbicides, and has a potentially sizable market for microbicides. 
Given the country’s relatively extensive clinical and regulatory experience with microbicides, and the 
urgency of the epidemic, it is likely that South Africa will be one of the first countries to introduce a 
microbicide once safety and effectiveness are established.  
 
Participants included community members and leaders, health care providers and managers, provincial 
and national-level government officials, and representatives from nongovernmental organizations and 
health professional bodies that influence policy. Interviews with policy makers and influentials were 
conducted at national and provincial (Western Cape) levels.  Interviews with local policy makers, 
providers, and community participants and leaders were undertaken in Langa, one of South Africa’s 
oldest townships*, situated on the outskirts of Cape Town.  
 
Langa was selected as the study site with the assistance of the project’s Local Advisory Group (LAG).  
Langa was established in the 1920s following passage of the Urban Areas Act, which forced Africans to 
live in demarcated areas based on race. Today, the township is a socio-economically heterogeneous 
community of almost 60,000; this is reflected in the diverse types of accommodation people live in, 
including an informal settlement area (Joe Slovo), rented accommodation (free-standing homes and flats), 
and home ownership, including formerly rented accommodation and suburban-type homes. 
  
Both HIV statistics and services are limited in the study community of Langa; however, select data 
suggest a growing number of HIV infection cases and AIDS related deaths (Table 1).** There are no 
available antenatal HIV prevalence data for Langa; antenatal HIV prevalence in the Gugulethu/Nyanga 
district, the nearest comparable townships to Langa, was 16 percent in 2001.  
 
Table 1. Trends in HIV Cases (1998–2002) and AIDS Deaths (1999–2002) 
Reported by Langa Community Health Center 
 
 
                                                 
* In South Africa, the term “township” referred to residential areas earmarked for black South Africans. Under 
apartheid in particular, townships became synonymous with a policy of political, economic, and social control. 
** These figures are not necessarily a true reflection of the prevalence rates of HIV/AIDS in Langa. There are 
numerous reasons for underreporting. These cases are only those reported at Langa Community Health Centre. 
People might present elsewhere, go home to the rural areas to die, or not be tested at all for HIV/AIDS. Figures are 
underreported in South Africa and often AIDS deaths are not recorded as death due to AIDS, but to other 
opportunistic infections such as pneumonia. 
 1998 1999 2000 2001 2002 TOTAL 
HIV cases 56 73 208 411 535 1,283 
AIDS deaths - 79 96 120 130 425 
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B.    STUDY DESIGN  
 
This qualitative study used focus group discussions and in-depth interviews to collect data from 
respondents. Research instruments were developed drawing on the project’s conceptual framework based 
on current discourse in the microbicide field, as well as issues that emerged from a literature review on 
introduction of other health technologies and innovations. The instruments were designed to be open-
ended and to include probes for potential additional issues that could emerge as important concerns 
among the various respondent groups.  
 
To refine language and adapt questions to respondent needs, instruments and informed consent forms 
were pre-tested among service providers and community members.  A district policy maker provided 
feedback on the policy maker interview guide. Following the pre-test, community instruments were 
translated to Xhosa and back-translated to English. Before conducting Focus Group Discussion (FGD) 
sessions, an additional nine pilot focus group discussions (six groups of women, three groups of men) 
were held by the community researchers in Xhosa in Khayelitsha, a nearby township. No data from these 
pre-tests are included in the research findings. 
 
C.    SAMPLING  
 
Respondents (also referred to as participants) were identified using a combination of purposive and 
snowball sampling. Overall, 23 focus group discussions and 38 in-depth interviews were conducted with 
respondents at the policy, service delivery, and community levels (Table 2). A more descriptive 
breakdown of participant characteristics by level of inquiry is included in Appendix 1 of this report. 
 




1.   Community respondents 
 
Community focus group participants all resided in Langa and were stratified by age, gender, and 
socioeconomic status, using housing type as a proxy (i.e., type of residence: rented, homeowners, or 
informal settlement). In addition, four focus groups were held with community members of special 
interest (sex workers and taverners*—see Appendix 1 for details). Respondents recruited for focus group 
discussions were approached individually by the Xhosa-speaking Community Liaison Officer (CLO) and 
briefly informed about the research project to determine their interest in participating. Those who fit the 
sampling criteria and were available and willing to participate were invited to attend the appropriate 
group discussion. Selection for the four focus groups of special interest differed in that the CLO recruited 
one or two participants who then brought other participants to the sessions. 
 
Focus groups were stratified by age: younger women and men (18-25), older women (26-58), and older 
men (26-45). The mean age of men and women participating in the study was 31.2 and 30.5 years 
respectively. 
                                                 
* The term “taverners” refers to people who frequent informal bars that serve alcohol. 
 Focus Groups In-Depth Interviews 
Provincial and National Policy  0 20 
Service Delivery  1 7 
Community  22 11 
TOTAL 23 38 
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Sixty-five percent of FGD participants owned or rented their homes and 95 percent were unemployed; 
there were no significant gender differences for both categories. Gender differences were seen in 
schooling: while 82 percent of the total had secondary education, more men (43 percent) than women 
(26.6 percent) had graduated from high school, but almost 16 percent of women as opposed to 5.4 percent 
of men had post-high school education (Appendix 2). 
 
Community respondents who participated in in-depth interviews included traditional healers, teachers, 
outreach workers, and individuals from key community organizations, including NGOs located in Langa.  
 
2.   Health service providers 
 
Public health nurses and doctors involved in reproductive health and HIV/AIDS services in Langa were 
contacted by phone or in person for interviews; private doctors were recommended by community 
members for interview. Individual in-depth interviews were conducted with three public health doctors, 
two private general practitioners, and two public health managers (also nurses) of local health facilities. In 
addition, one focus group discussion with five nurses was conducted. 
 
Public health managers were women with nursing backgrounds, and all five public health nurses were 
women, consistent with the gendered nature of nursing in South Africa. They worked in the areas of 
maternal, child, sexual, and reproductive health. Given the limited health services in Langa, both the 
public health doctors and private general practitioners had considerable experience with communicable 
diseases, including HIV/AIDS and STI treatment and management.   
 
3.   Policy makers and policy influentials  
 
The LAG and local researchers identified policy makers and policy-influentials (i.e. individuals who 
shape reproductive health and HIV/AIDS policy and programs). Policy makers interviewed included 
high-level managers and directors working in reproductive and sexual health, and HIV/AIDS directorates 
in the National Department of Health and the Western Cape provincial Department of Health. 
Respondents from the nongovernmental sector included local and international advocacy and service 
delivery organizations involved in HIV/AIDS, STIs, reproductive, and sexual health. Professional 
medical bodies and representatives from the media also were included.  
 
 
D.    DATA COLLECTION 
 
Principal investigators, a senior researcher, and a project coordinator 
from UCT/WHRU were responsible for daily oversight of data 
collection and all field-based research activities. They also conducted 
policy maker and service provider interviews. Focus groups and 
some interviews with community members and leaders were 
conducted by a trained team of Xhosa-speaking community 
researchers.  
 
On average, focus group discussions lasted approximately 1.5 hours 
and in-depth interviews lasted 1 hour. Informed consent was 
obtained from all participants prior to interviews and FGDs. For 
statistical purposes, confidential socio-demographic characteristics 
were collected on all FGD participants. Along with a description of 
Carraguard : one of several 
microbicide products currently in 
development, including some in 
Phase II and Phase III of clinical 
testing. 
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hypothetical microbicide products, an applicator similar to the one used in the Carraguard  clinical trials, 
pre-filled with K-Y Jelly, was shown to community participants as an example of a potential microbicide 
product.  
 
Focus group participants received 30 Rand (approximately US$4) to cover transportation costs incurred to 
attend the sessions, and refreshments were also provided during sessions. Interview respondents received 
no compensation. All interviews and sessions were tape-recorded and the tapes were later transcribed 
verbatim in English. Community in-depth interviews and focus groups conducted in Xhosa were 
simultaneously translated and transcribed into English by a professional translation/transcription service.   
 
 
E.    DATA ANALYSIS 
 
Data analysis was performed using a modified grounded theory approach—a process that allows 
researchers to “discover” categories, themes, and patterns that emerge from the data12. To facilitate data 
management and sorting, Atlas.ti, a software package developed for qualitative data, was used. Initial 
categories for analysis were drawn from the interview guides, and additional themes and patterns emerged 
after reviewing the data within and across respondent groups. In May 2003, the entire research team met 
in Cape Town to review all data, identify major trends and cross-cutting themes, and prioritize issues for 
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III. STUDY FINDINGS 
 
 
A.  INTRODUCTION TO FINDINGS 
 
Research findings are presented according to both topic and the levels of inquiry to which they have 
particular relevance. This section begins by presenting findings on general issues that relate to all three 
levels of inquiry, including the need for microbicides, partial effectiveness, and information needed to 
facilitate recommending or using microbicides. It explores and contrasts perspectives of all respondent 
groups to provide readers with a broad view of how the range of study respondents perceived the same 
issue.  For example, did community, providers, and policy makers understand the need for microbicides 
in the same way, or did their perspectives differ based on their background and exposure to the issues? 
 
The subsequent sections correspond to the study’s three levels of inquiry: community, service delivery, 
and policy. Each section includes topics that are of particular relevance to that level of inquiry, and 
presents the perspectives of all respondent categories together. For example, the issue of covert 
microbicide use is discussed under findings relevant to the community and includes providers’ and policy 
makers’ perspectives as well as those from the community level in order to compare and contrast views. 
In some instances, only one or two respondent levels are included, indicating that there was little data 
from the other group(s). This section on study findings is followed by discussion of the results and 
recommendations.    
 
 
B.    GENERAL FINDINGS  
 
This section presents findings on topics that are relevant across all three levels of inquiry—community, 
service delivery, and policy—and draws on responses from all respondent categories. Within these 
general areas, respondents voiced a broad range of perceptions and opinions. Their reasons for supporting 
microbicides tended to focus on the desperate need for more prevention options in light of the HIV/AIDS 
epidemic, the recognition that many individuals do not use condoms, and the limited power of women to 
negotiate a male-dependent method. Partial effectiveness was the major concern expressed by most 
respondents. In addition, a wide range of individual concerns and questions about microbicides emerged 
from the data. The following sections present the most common reasons for microbicide support, as well 
as a range of concerns related to microbicide introduction.  
 
1.  Support for microbicides  
 
Although respondents across all three levels of inquiry understood particular aspects of microbicides 
differently (for example, how they could be used, who should use them, how they would work, and so 
on), the vast majority clearly saw the need for microbicides and was supportive of microbicide 
introduction.  
 
While it was expected that a case would need to be made for microbicide introduction, results suggest that 
there is already a strong case for microbicides in South Africa. Respondents at all levels recognized and 
often spontaneously and eloquently articulated the limitations of existing prevention options, as well as 
women’s particular vulnerability to HIV infection, including the social and economic constraints that 
condition their risk of infection. Respondents, particularly community members and providers, conveyed 
a sense of desperation and urgency for additional prevention options in light of the devastating impact of  
the HIV/AIDS pandemic in South Africa. Community respondents evinced a marked sense of desperation 
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and urgency in the face of the epidemic, while many service providers voiced a feeling of despondency. 
The feeling of powerlessness and confusion was expressed by many, including one male focus group 
participant who noted, “Everyone is at a loss about this AIDS.”  
 
Overwhelmed by a tragedy unfolding on their doorsteps, almost all community respondents supported 
introducing even a partially effective microbicide product due to the severity of the situation in South 
Africa and the need to take action. Without probing, respondents often raised the subject of burials of 
people who have died from AIDS as a daily feature in their lives. “…We are dying like fleas,” was how 
one community woman articulated the enormous impact, while a male community member explained:  
“No one will not want to use this method because we are getting finished out here, we 
bury everyday…this medicine will help us not to die the way we do.” 
—Man (26-45 years), owner 
 
Similarly, one community leader suggested that sexually active people of all ages would be interested in 
using microbicides because “they can now see that our nation is dying.”  
“I'm sure everybody will want [this method], because everybody wants to know how they 
can protect themselves. It’s terrible out there, people are dying, there's a child who has 
just died from HIV at the place where I come from. They are getting finished and they 
really get sick when it gets to this stage. AIDS is a difficult issue.”  
—Community leader 
 
Dying or “getting finished” were predominant signifiers in the discourse on desperation and urgency. 
Community respondents repeatedly spoke in these terms about microbicide use, which many saw as a 
choice between life and death. One male focus group participant described the method as “interesting for 
those who did not want to die.”  
 
Many health service providers were despondent in the face of the epidemic and their limited ability to 
help prevent or treat the disease. “I would do anything. I would do anything to prevent the spread of 
infection. Whatever helps,” one public health doctor said. 
 
Providers related their concerns and frustrations to their experiences as health care providers. They 
conveyed a sense of being overwhelmed and feel the need for more alternatives as they care for infected 
and dying patients. Providers commonly spoke about the need for more options in the face of epidemic 
levels of STI infections. 
“Well, if it’s [microbicides] something that is going to lessen the spread, I’m thinking 
that is going to be very important...because we as carers, we would love to see such 
things happening, because at this moment in time really our hands are full in the HIV, 
STIs areas.” 
—Public health manager 
 
Like community members, some providers also spoke of their sense of desperation as a result of being 
confronted with a growing HIV epidemic.   
 “I would accept any help – I would be prepared to try anything. I’m so desperate I just 
want to try anything.” 
 [Interviewer:  “Really? Is it that bad?”] 
 “It is. It is. It is bad.” 
—Private doctor  
 
While this sense of desperation was common among community respondents, providers, and some policy 
makers, other policy makers voiced a more cautionary sense of need. With some distance from the death 
and devastation, many policy makers recognized the need for more prevention options, but felt that all the 
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benefits and limitations of a potential microbicide product should be weighed before approval or support 
for the product could be offered.  
 
2. Condom substitution/migration  
 
The fear of condom substitution (condom users switching to microbicides, sometimes referred to as 
“condom migration”) has been cited as a potential barrier to the widespread endorsement of microbicides 
as a potential method of HIV prevention.9 Findings suggest that while this was an issue of major concern 
among participants, participants did not generally feel that it was a reason to not introduce the method. In 
many cases, concerns related to condom substitution were tempered by a broad recognition of the 
difficulties and limitations of condom use.    
 
Problems associated with the use of male condoms were raised by most community members, including 
some community leaders. Opinions varied about the likely impact of microbicides on condom use, 
specifically whether people would abandon condoms in favor of microbicides. These responses often 
reflected people’s personal experiences. Similarly, policy influentials and providers expressed varying 
levels of concern about the possibility of condom substitution with the introduction of microbicides. 
Several national and provincial key policy influentials and providers felt that condom substitution was a 
real “worry” or “quite a big challenge.”  
 
Those who expressed deep concerns often looked to the possible detrimental impact on young peoples’ 
use of condoms which, they assessed, was on the rise. Nonetheless, policy makers, policy influentials, and 
providers recognized that condom use was neither universal nor consistent even among “condom users.”  
While several policy makers felt that condom use was increasing, others recognized the difficulties of 
assessing if, how, and when men and women were actually using condoms. 
 
When asked how microbicides would fit into existing HIV/AIDS counseling programs, many policy 
makers and providers were torn between a desire to provide clients with choice, and a need for strong 
public health messages that emphasize condom use. One respondent was particularly concerned about the 
consequences of clients’ choices. 
 “That’s my worry from a public health point of view, it would be, ‘Well, now you’re 
potentially putting them more at risk than they were before by giving them this 
alternative.’…How to stop that? Not easy. … You give people choices but that’s why I’m 
a little bit worried about the consequences of that.” 
—Provincial policy influential 
 
A few providers, wary of the idea of recommending that microbicides be used together with condoms, 
feared that, if asked to use two methods, clients might choose microbicides over condoms. Some feared 
that this could undermine already low condom use and previous work around condom promotion.   
“Trying to get them to use a condom is very difficult and now we are asking them to use 
two things instead of one thing. That would be a problem for me as far as education goes. 
And then again, they might just decide that I can use only one of two and then might opt 
for the microbicides rather than the condom.” 
—Public health physician 
 
Some male focus group respondents indicated that they may indeed stop using condoms, underscoring the 
concern of policy makers and providers. They felt that with the introduction of the microbicide they 
would no longer need to use a condom and that their partners would appreciate this, as women do not like  
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condoms either. Some women in focus groups expressed similar sentiments regarding their discontinuing 
condom use. 
“What will give interest in this cream is the fact that we won’t have to use a condom 
anymore, which is what men want, so when applying the cream underneath, men will be 
happy. There will be no problems like there were previously with a condom. It will now 
be the flesh-on-flesh that they insist.” 
—Woman (26-45 years), informal settlement 
 
In contrast, a national policy maker agreed that there was “more confidence in condoms than ever before” 
but felt that the introduction of microbicides would not decrease condom use. A provincial policy leader 
noted that the introduction of the female condom had not brought about a significant decrease in the use 
of condoms and microbicides would likely prove no different. The participant felt the “more options the 
better;” and that women should be able to choose their method of protection based on their own situation.  
 
Community leaders raised some concerns about condom migration but felt overall that the microbicide 
could potentially provide an important alternative to condoms, which are unpopular. One respondent was 
not particularly concerned about condom migration. She felt that in the context of the AIDS epidemic and 
low condom use, the microbicide would provide a positive alternative. She later suggested using a 
microbicide in conjunction with a condom.  
“… But I think also the idea of [microbicides] must not be separated from a condom. I 
strongly believe that the one must not be an alternative of the other. I think like 
contraception and condoms, they must come together. I think this microbicide and a 
condom, I really think that they should be seen as being partners, and that when you use 
them both, instead of being 99.9% with condoms or 70% with the microbicide then we'll 
be having 150%, with both of them.” 
—Community key informant 
 
Both policy makers and providers felt that through selectively offering microbicides to certain groups of 
clients, condom substitution could be minimized. Several providers stated that they were not overly 
concerned about condom substitution because of microbicide introduction. Asked if she would be 
concerned if clients stopped using condoms, one provider said, 
“I don’t think so, it’s just choice…I think, for those that don’t like [condoms] anyway 




Men in focus groups were not uniform in their attitudes towards condoms, recognizing that “people are 
not all the same.” Issues around condom substitution were not clear-cut and male community members 
grappled with the implications of not using a condom versus using a method that was not 100 percent 
effective. 
 
Finally, findings confirmed what has been widely reported elsewhere about people’s dislike of condoms, 
difficulties using condoms, and inconsistency of use. A provincial policy maker remarked, “We’ve had 20 
years of AIDS but … I think we no longer fully appreciate the complexity of condom use.” Women in 
focus groups frequently mentioned men’s reluctance and/or refusal to use condoms. The microbicide 
would thus not only provide them with a female-initiated alternative but also one that would also be 
“attractive” to men, largely because “they are always reluctant when things are made for them” and 
because women and not men will have to use it. In addition, because microbicides may be the only option 
for some women, failure to provide microbicides could place policy makers in a “difficult ethical 
position.” Since many men refuse to wear a condom because it inhibits sensation, women felt 
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microbicides would be more attractive vis-à-vis condoms. “They will be able to eat the sweet without the 
wrap.”  
 
3. Gender-power dynamics limiting women’s ability to negotiate 
condom use 
 
Policy makers, providers, and women all acknowledged the difficulties women face in negotiating 
condom use, while several male community members did not agree that women had limited power to get 
their partners to use condoms. Both provincial and national level policy makers recognized that a 
woman’s attempt to convince her partner to use a condom could result in domestic violence and 
accusations of infidelity. Policy makers, in particular, frequently referred to women’s “lack of power” in 
sexual relationships as a compelling reason for providing female-controlled alternatives to HIV 
prevention.  
 
Community women often noted that it was generally difficult, although not impossible, to negotiate 
condom use with male partners. One woman stated, “Men don’t want women to have a say, especially 
regarding sex; even with the condom, they complain.” Many women said that condom use could be 
associated with complaints, mistrust, fights, and even violence or abandonment. A nurse participating in 
one focus group said, “Women are the ones that should always negotiate … and it’s difficult for them.” A 
microbicide’s potential to offer an alternative when men refuse to use condoms was a recurring theme 
expressed by women in discussing their desire for a prevention method that they themselves could 
initiate. “When one wants the partner to wear a condom, they refuse and accuse one of sleeping around, 
but with this, one is in control. One can simply put it on and be safe.”  
 
Several participants suggested that covert use might be particularly desirable for young girls due to their 
lack of power in sexual relations, indicating that they could use microbicides “and nobody would be the 
wiser.” If men knew about microbicides, they may feel that it could undermine their power in sexual 
relations.  
 “…at least one knows one is protected because some men beat you up for using a 
condom and want to find out why…At least there would be no problems, you would know 
that you are safe, even though you would not tell a man, you would personally know that 
you are safe.” 
—Female taverner  
 
Providers and policy makers alike considered microbicides as a potentially empowering option to women 
who had few or no realistic prevention options. An informant from the media spoke about the limitations 
of other STI and HIV prevention methods and the inability of many South African women “to negotiate 
safe sex with their partners,” concluding that the microbicide would provide an empowering alternative. 
 “It’s [microbicide] an empowering tool really. Women will be able to actually decide 
what happens in their sex lives. They will be able to control that [by saying] that ‘This is 
where the buck stops. I'm not going to get HIV because nobody should get it.’” 
—National policy influential 
 
Some men from the community said they would support a female-initiated method. Despite this, many 
women were skeptical as to the likelihood that men would actually support the use of microbicides in 
their own sexual relationships. Others believed that men would see this as a “good thing,” since they did 
not want to wear condoms.  
  “Yes they will be interested…Because most males do not want us to use a condom, and 
therefore this microbicide will be most helpful towards us women.”  
—Woman (26-45 years), informal settlement 
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While a few men in one focus group discussion spoke about how the microbicide would enable women to 
have some “power and control” over their sexual practices, most male community members saw the 
situation differently. Although several men spoke of their (or their partners’) dislike for condoms, they 
suggested that they generally “give in” and go along with whatever their partners may suggest.  
“Men are also easy to convince, so if this will be admitted by women and moreover get 
used by them, we males will vote for it, because if a woman says, I'm using such and such 
a method and you disagree, you will end up giving in.” 
—Man (26-45 years), owner 
 
Several women in community focus groups suggested that even if men were to support microbicide use, it 
be motivated by a desire to allow them to continue engaging in risky sex, not to support women. Women 
in focus group discussions said that men would exploit microbicide use by seeing it as an opportunity to 
“sleep around as much as they like,” and that an added attraction for men would be that “this would make 
it easier for them to sleep around and still not get infections.”  
 
A few providers and policy makers also felt that the microbicides may give men reason to refuse condom 
use, and that their existence could mean that women wouldn’t have as much leverage to insist on condom 
use. Others, including one public health doctor, emphasized that a single product could not be expected to 
“empower women,” stressing that empowerment was in fact a much larger process requiring the change of 
inequitable socio-cultural expectations and gender norms.  
 
4.   Partial effectiveness   
 
The issue of partial effectiveness concerned many providers and policy makers. However, the range of 
individual concerns expressed about introducing a partially effective product, and the challenge this 
would present for information provision and distribution strategies, were generally tempered by a wide 
recognition that even a partially effective product would provide an important additional option for 
women and men and could increase overall protection.  
“It's important for people to understand that condoms on their own are not going to be 
100% safe, but it's also important from the point of view that there are people advocating 
that we must not be introducing technologies like condoms or like microbicides because 
there is a risk associated with them. Yes, there's still a risk of transmission associated 
with them, but we need to understand that the type of shifts in overall risk profile that are 
needed in South Africa will be achieved by the cumulative effect of a number of 
strategies, getting people to wait ‘til they're older to have sex, sticking to one partner, 
persistent condom use, and so the microbicide is yet another additional piece of armor, if 
you like, in the overall fight against HIV/AIDS.” 
—National policy influential 
 
A few policy makers and providers suggested that partial effectiveness of a first-generation microbicide 
was a trade-off to the high need and demand for such a product. One policy maker saw first-generation 
microbicides as prototypes for additional prevention technologies in the future, and that demonstrated 
demand would promote the development of more prevention options.   
 
When first told that first-generation products might be between 40 to 70 percent effective, some 
community respondents and a few providers were confused about what this meant. Some struggled with 
understanding and using the terminology, often resorting to using effectiveness, efficacy, and safety (from 
infection) interchangeably. A few providers also expressed concern about how such complex concepts 
could be explained to clients. However, most providers did recognize that no method was “one hundred 
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percent” effective, including condoms, and that while “some people are comfortable with condoms, 
[other] people are not.”  
 
Nonetheless, a few providers had concerns about offering microbicides as a stand-alone product, with one 
provider suggesting that offering microbicides when there are more effective methods could be 
considered “unethical medically.” Some providers explained that they would be uncomfortable offering a 
partially effective product, thereby exposing clients to a partial risk of infection. One private physician 
insisted that microbicides should only be offered along with condoms, comparing the use of microbicides 
alone to “wearing a bulletproof vest that’s 50 percent effective…If you wear a bulletproof vest that's 50 
percent effective, I mean would we go and ask someone to shoot you in the chest?…Use condom at all 
costs.”  
 
Several providers suggested that, given their partial effectiveness, microbicides should only be made 
available along with condoms to stress the method’s limitations.  
“40 percent is bad… But, you know, I think that one must be upfront with patients about 
that fact and really stress that this can only be used in conjunction with a condom, I mean 
unless it's absolutely impossible, then it can't be relied on. But I mean I would hope that 
you would be able to improve on that.” 
—Public health physician 
 
A few policy makers and providers expressed concerns about the potential legal and political 
repercussions of introducing a partially-effective product. One public health manager worried that 
promoting use of a partially-effective microbicide might backfire on providers, who could become 
perceived as negligent for promoting a product that people use yet still become infected. 
 
Finally, while some policy makers and providers were asked to comment on the “prevention equation” 
described in the introduction above, respondents had little reaction to this concept (that a less effective 
prevention method used more consistently could have a greater impact on preventing infections than a 
more effective method used less consistently), and in general the interviewers did not probe. Despite lack 
of data in this area, it is worth noting that it was not a concept that seemed to resonate with respondents.  
As stated previously, respondents expressed broad support for microbicides in light of the devastation of 
the HIV/AIDS epidemic, the vulnerability of women to infection, and the recognition that condoms are 
not used widely or consistently. The argument presented by the “prevention equation” appeared to 
contribute little to developing this support; this may be because it was not well understood, or because 
such evidence was not needed in this context.   
 
5.  Who should/would use microbicides?  
 
Responses varied by and among respondent groups to the issue of the most appropriate and likely users of 
microbicides. Community-level respondents suggested that microbicides would or should be used by 
people of different ages, including very young girls and older women and men, suggesting that every 
person who was sexually active would be an appropriate potential user. While some policy makers and 
providers concurred, others felt that access should be restricted to what respondents defined as “high risk 
groups,” which in most cases included most individuals at risk of infection, with the exception of young 
people.    
 
a. Range of potential users 
 
Respondents thought that a wide range of people could be potential microbicide users. Community 
members suggested that women of all ages and even children from a very young age should have access 
to microbicides because of their vulnerability to sexual abuse. At the same time, some suggested that 
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older married men and women should use microbicides because they are still sexually active; because 
older men might have sex with younger women; and “because our husbands sometimes will also have a 
feeling to do something with us.” A number of focus group participants thought that married persons 
would be likely to use microbicides because they were not in a position to negotiate condom use.  Some 
community members thought that women and men who wanted to have children would be particularly 
interested in using microbicides if they allowed conception while preventing disease.  
 
While many community respondents assumed a quite inclusive stance toward potential user groups, some 
women in focus groups saw sex workers as among the most appropriate users of microbicides. Sex 
workers were perceived to have unprotected intercourse with many different men in the course of their 
work, which practice was understood as conducive to the spread of STIs. Several participants in a focus 
group of nurses wanted to know whether HIV-positive clients or clients with other sexually transmitted 
infections would be able to use microbicides.  
 
Data also suggested that providers tended to approach the subject of who should use microbicides 
somewhat differently from other respondents. They were more comfortable categorizing appropriate 
microbicide user groups according to risk, usually based on medical history, particularly history of STIs, 
and those who were unable to negotiate condom use. Providers tended to cite the broader range of risk 
factors for HIV such as number of sexual partners, ability to negotiate prevention options, and/or the 
dynamics of sexual relationships rather than characteristics such as age or marital status.  
 
Other providers proposed limiting microbicide access to what they defined as “high-risk” groups. Yet 
when asked to clarify who they considered to be “high-risk,” providers generally listed the same groups 
of individuals suggested by community members, adding individuals such as those with a history of STIs, 
HIV sero-positive individuals, commercial sex workers, those with latex allergies, and youth. A few 
providers felt that only those who were screened and found to be “high-risk” should be offered 
microbicides, saying that the method should be considered a “second line measure and not as a part of 
the front line intervention,” offered only to those who have defined risk factors.  
 
b. Youth as potential users 
 
There was considerable support among community members, including youth themselves, for young 
people to be among the main users and beneficiaries of a future microbicide. This was based on a number 
of reasons—they are the most sexually active, do not use condoms, and are the most vulnerable to 
unplanned, unprotected, and coercive sex. Youth (defined by the community members as between 12 and 
30 years of age) also were not “getting it” (that is, not understanding the serious nature of the epidemic), 
and they saw more youth as dying from AIDS than adults. One young woman stated, “Well, us 
youngsters are promiscuous, you’d never hear of an older person dying of AIDS. It’s more prominent on 
us, so we have to use this method.” Because focus group participants perceived that the sexual debut of 
youth was occurring at a very young age, they said there should not be age restrictions on microbicide 
users.  
 
One policy influential stressed that adolescents should have access to microbicides, noting that children 
12 to 14 years old “are having sex because of poverty…You have to have this readily available for those 
girls.” Some providers were also willing to include youth among potential users, recognizing the 
epidemic rates of STIs among this group. There were policy makers and a few providers, however, who 
were reluctant to offer the option of microbicides to youth, saying that youth would not have the ability to 
comprehend the implications of partial effectiveness and that it could undermine recent gains in condom  
 Paving the Path: Preparing for Microbicide Introduction ! 25 ! Qualitative Study Report  
use among young people. Finally, a national policy leader stressed the important role a microbicide 
product could play for young women given the power dynamics present in many sexual relationships: 
“That 10 percent of girls who are having sex are the ones who are where the man is most 
likely to not allow them to use… a condom…and so providing them with a technology 
that is outside of those sexual dynamics could be very helpful.”  
 —National policy informant 
 
A troubling finding was that the possibility of young children being raped was frequently raised by 
community women during focus group discussions. Several community women and men thought that 
there should be no age limit set for users of microbicides and expressed this through an acute sensitivity 
to the possibility of children five years old or younger being raped. “[Microbicides] shouldn’t have an 
age restriction…even if a young child gets raped, with the substance applied…they can get protected 
from infections.” 
 
C.    FINDINGS RELEVANT TO THE COMMUNITY  
 
Issues of greatest importance and relevance to community members centered on concerns that impact 
people’s daily lives—rape, violence, and partner relationships—and how microbicides might affect them. 
Discussions focused on whether there is a need for use without a partner’s knowledge and whether this 
would be possible; pros and cons of partner involvement; how the characteristics of microbicides interact 
with sexual practices and beliefs; and how experience with other intravaginal products might affect use of 
microbicides. This section covers what respondents, primarily community members, described and what 
they perceived to be desirable and undesirable product characteristics, including serious concerns about 
whether microbicides might harm women’s ability to become pregnant. It also presents approaches 
suggested by all respondents to develop support for microbicide use at the community level.  
 
1.   Rape, violence, coercion, and unplanned consensual sex 
 
Community respondents described and discussed a range of situations in which microbicides could be 
used.  A predominant theme was the need for a product that would be long-acting and could be inserted 
before leaving the house as a routine practice in case something unexpected or unplanned happened that 
would expose them to risk of HIV infection. The most common concern was about rape, which was 
discussed at length. Other situations cited were those where a woman might have unplanned but 
consensual sex, and in which a man might attempt to infect them intentionally, whether through rape or 
deceitful consensual sex. It should be noted that the themes of rape, coercion, and unplanned sexual 
intercourse were not included in any of the research guides, but emerged spontaneously as major concerns 
raised by women in all community focus group discussions, a few men in focus groups, and a number of 
individuals interviewed at the community and policy-level. Interestingly, only one provider discussed the 
issue of rape. Most raised the risk of being raped as a potentially important application for microbicides, 
and as a reason to support microbicide use on a personal or more widespread level.*  
 
a. Rape  
 
Issues of sexual assault, including rape, while not directly probed for in this research, emerged strongly as 
key concerns of community members across age and socioeconomic status. FGD participants, as well as 
several national policy makers and policy influentials, recognized that women, adolescents, and (as 
previously noted) children, were frequently at risk for rape or coercive sex. One policy maker, in 
                                                 
* The issue of rape in South Africa has been studied and received substantial attention in media and public discourse, 
which could partially explain the high recognition and frequency of spontaneous reporting of this issue among 
respondents. 
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recognizing this as an important potential use for microbicides, was troubled by the reality in which 
women need such a product in order to protect themselves from rape or coercive sex:  
“Indeed in cases where the sex [is] without consent, [a microbicide] is something that 
you can have in there and no one would actually know about it and it would be protective 
for the female. Of course, I hate it that women have always to think about whether they 
are going to be sexually abused, assaulted, et cetera, but in reality that is what's 
happening so one has got to be aware…if the occasion arises that you are forced to then 
you know at least you've got some chance of surviving.” 
—National policy influential 
 
Many female respondents and some providers conveyed desperate feelings about the risk of rape. Several 
women in FGD talked about “surviving” rape without HIV infection, anticipating or assuming that 
microbicides would afford protection for an unspecified, yet lengthy, period. This possibility of regular 
use of a microbicide was suggested by a number of participants. One woman said she would “prefer that 
it’s used all the time, it could so happen that one gets raped.” Women talked about applying “the cream” 
as part of their daily routine in order to leave their homes prepared for any eventuality. As previously 
stated, they also talked about using microbicides to protect children from infection in the case of rape, 
suggesting the prevalent fear of sexual violence at the community level. During an interview, a 
community member suggested that women “should voluntarily use it [microbicides] because they could 
be raped anywhere.” Reflecting the scope of concern and risk, a national policy maker stated, “I mean 
even an 80-year-old can be raped at any time.” A young male focus group participant also said, “I wish it 
[microbicides] gets applied all the time because one wouldn’t know if they [women] could get raped.”  
 
Women were very enthusiastic about the potential of having something that could offer protection in the 
perceived high likelihood of rape. 
 “I was going to support the cream (i.e. microbicides) that will protect us from rape 
situations, because I will never get infected with a disease when I apply the cream.”             
—Woman (26-45 years), informal settlement 
 
However, as this quote suggests, in their enthusiasm for a solution, many women seemed unconcerned 
about the issue of partial effectiveness. This perception reinforces the concerns expressed by some 
providers and policy makers about the implications of introducing a partially effective product without 
sufficient information about the product’s limitations, particularly given the level of desperation for 
additional prevention options, as reflected in the discourse on rape.  
 
b. Deliberate infection 
 
The idea that HIV-positive people deliberately infect other people heightened community members’ 
feelings that availability of microbicides should be a priority. Women could use the product to protect 
themselves against anyone who might be trying to infect them through rape or deceit about their HIV-
status. They said that “the cruel ones,” those that know they have the virus, deliberately spread it by 
sleeping with everyone because they “tell themselves that they won’t die alone.”  Both women and men in 
focus group discussions voiced concern about deliberate infection.   
 “I see it as very helpful because some people commit rape in order to spread the 
disease.” 
—Woman (18-25 years), informal settlement 
  
“If it could be 100 percent effective, women will use it a lot, because there are AIDS-
infected men who rape women, so a woman would walk in the streets knowing very well 
that she is protected even if an AIDS-infected person would rape her.”  
—Man (26-45 years), homeowner 
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c. Unplanned consensual sex 
 
Many female community members viewed microbicides as affording protection from infections in 
multiple high-risk situations, including many in which sex might not be anticipated. Many assumed that 
or asked about whether the product would stay in place if they inserted it before they went out for the 
evening. Respondents indicated that they would want to apply microbicides before going out in case of 
unexpectedly meeting their boyfriend, or before going to parties in case of meeting someone and having 
sex. A female focus group participant described such unplanned sex that occurs in the taverns: 
“Because in most cases that’s where most people meet [taverns], get drunk, and get 
horny, and have quickies in the toilets.” 
—Woman (26-45 years), renter 
 
A provider echoed community members’ views of the need to be able to insert the product ahead of time 
in case sex occurs. She articulated the challenge in applying a product immediately before unplanned sex, 
describing the context of housing without privacy.  
“The problem is that you won't know you never know whether you're going to have sex or 
not. People stay in small rooms all in one room where they can't even say ‘I'm going to 
the toilet quickly’ and then put it [microbicides] on. You know? How long must you wait 
in the toilet…” 
—Nurse 
 
2. Partner involvement and covert use  
 
The possibility of covert use or use without a partner’s knowledge was an early premise of microbicide 
development. Given that covert use may not be desirable or even possible with all products under 
development, focus group discussions and interviews probed for perspectives on covert use and partner 
involvement. A range of opinions emerged from these discussions, some supporting the need for covert 
use, some questioning the feasibility of covert use.  In addition, many respondents felt strongly that 
involving partners in microbicide use was both ideal and feasible in many circumstances.   
 
a. Partner communication and involvement  
 
Both male and female community respondents expressed strong support for open communication about 
using microbicides. Both men and women indicated that some men could be compelled to agree to use 
microbicides with their partners once they understood that it protected against STIs and HIV. Women 
suggested that certain types of men, such as men who care about themselves and their partners, are more 
likely to want to be involved in microbicide use.  
“If a man loves you, he shouldn't have a problem with it. This would need the 
cooperation of both partners.” 
—Woman (18-25 years), renter 
 
Women believed that men who understood the gravity of the AIDS epidemic because they had personally 
witnessed the effects of AIDS on the community would be most likely to support their partners’ 
microbicide use. Men also perceived that their partners were likely to have a positive attitude toward 
microbicide use if men introduced the subject. Some even suggested sharing responsibility for use and 
that partners should take turns putting the product into the woman’s vagina. 
 
Many women felt that communicating with their partners about microbicide use was both important and 
feasible. One sex worker felt that agreement on the importance of microbicide use could be reached 
through open communication and adequate information to alleviate suspicions. Some women stated that 
men could be reasonable, caring, and open to negotiating microbicide use. They felt that, at the risk of 
being told no, they could propose the method to their male partners to see if they “would like it or not.” 
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Some male and female FGD participants expressed the importance of partner involvement, stating that 
“partners can communicate and the other should make a man aware of what they are using and state that 
it’s to prevent infections.” The importance of expressing the reasons and intentions for microbicide use 
were frequently discussed as the proactive way to dispel mistrust and negotiate use.  
“I would tell him that I'm not seeing anyone, I'm only preventing from this existing 
disease, let's just use the cream.” 
—Woman (26-45 years), informal settlement 
 
In addition to communication between partners, female participants also suggested that information 
acquired from peers and men’s communication networks would be important to support men’s 
willingness to use microbicides once proposed. One woman said that this would be important because 
sometimes “men did not want to listen to what women had to say.” Another participant from the same 
group suggested that workshops consisting of both men and women should be held to facilitate partner 
dialogue and better prepare men to express themselves in the presence of women. A community leader 
echoed these women’s views, supporting male involvement and partner communication:  
“The best way of involvement is through education. Knowledge is power. They shouldn't 
get to know about it from hearsay or see it being used at home behind their backs. They 
might think that the woman is implying that he is unsafe.” 
—Community informant 
 
Despite extensive discussion about the fact that men and women do not trust each other, trust was 
commonly reported as necessary for effective partner communication. Respondents felt that trust would 
enable women to negotiate microbicide use with partners, which would be preferable to covert use. 
“It would be nice if partners could understand, such that we apply the gel in front of 
them, if partners could trust each other as opposed to applying it on the side.”  
—Woman (26-45 years), renter 
 
b. Covert use 
 
While most community members conveyed a strong desire for communicating with and involving 
partners in microbicide use, many felt that, in the context of certain relationships, covert use would be a 
necessary alternative. This was particularly true where there was a lack of trust between partners, where 
women lacked the power to negotiate the product’s use, or where they feared the repercussions of 
communicating with partners about microbicide use. Other respondents suggested that women should 
have the right to privacy and to choose whether to inform their partners that they are using a microbicide. 
 
Men’s likely opposition to microbicides was the primary reason cited for covert use. Female community 
members said that they would use microbicides without their partner’s knowledge if a male partner was  
“difficult,” was generally opposed to using prevention methods, or if they suspected that their male 
partners had other partners.  
“Our boyfriends are stubborn and they sometimes force themselves on us and take 
offence at the suggestion of safe sex. They take that as an implication that they might 
have AIDS forgetting that one is trying to protect them as well. So, this would be very 
helpful.” 
—Woman (26-45), homeowner 
 
Several women suggested that covert use would be a more feasible option than overt use because of 
women’s lack of power in sexual relationships.  
“I think it will be difficult for men to use it, because men don't want women to have a say 
especially regarding sex.” 
—Woman (26-45 years), homeowner 
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Some, such as this community nurse, speculated that covert use allowed women to avoid dealing with 
men’s potential suspicion at a women’s suggestion that the couple use a microbicide. 
“Men … might take offense at not being trusted when the wife is using it and might also 
think the wife is two-timing them. There must not be a secret between a man and a wife, 
especially between a girl and a boyfriend.” 
—Nurse 
  
Drawing analogies with contraceptives, some women felt that covert use could afford women protection 
while men would remain unaware of it.   
“…If you dare tell a man that you are using that method it will poke them causing 
discomfort and everything else you can imagine. Yet, if you keep quiet about it, you’ll 
never hear a single complaint. So that’s how men are.”        
—Woman (26-45 years), homeowner 
“I'm telling you this gel will work because it is inserted inside unlike the condom they are 
lazy to use, because they don't want to tear them. This is inserted and enters the system 
and men will not feel what's going on inside, because they felt nothing on the caps we 
used, we told them nothing about it, and they did everything.” 
—Community leader 
 
Providers, policy influentials, and policy makers also recognized the importance and utility of covert use.  
As one doctor in the public health sector noted, “Everybody wants to have some kind of secret, and some 
kind of privacy, you know.” Policy makers and key policy influentials expressed similar sentiments and 
felt that a method which was both “self-controlled” and “discreet” would be attractive to women. 
 
Independent of the reason why women would choose not to disclose microbicide use, some community 
members saw it as an issue of woman’s choice.  
“It will be a woman's choice not to tell their partners about it, because it is for 
preventing herself.” 
—Woman (26-45 years), homeowner 
 
c. Limitations and potential repercussions of partner communication  
and covert use 
 
Despite strong support for partner communication, as well as wide recognition of the benefits of covert 
use, both men and women expressed some reservations about the feasibility of covert use given the 
description of potential product characteristics.   
“Okay, if my partner doesn't want to use either, a condom and this gel, will he not be 
able to feel that I have some substance applied underneath?”                      
—Woman (26-45 years), informal settlement 
 
“If someone has used it, definitely it is going to be easy to identify that there is something 
inside because this is like a gel as you have explained. There is no way someone can hide 
it.” 
—Man (18-25 years), informal settlement 
 
Several providers, policy makers, and key policy influentials were also skeptical about the notion that a 
female-initiated method did not need to be negotiated and that microbicides could be used covertly.  
Similar to what was discussed among community discussion groups, two doctors in the public sector also 
felt that incorrect application or the microbicide’s texture or smell would make invisibility, and thus 
covert use, impossible. A national policy key influential and others asked if covert use would even be 
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feasible if microbicides came as a “thick cream” and “the guy pulls out and his penis is full of that thick 
cream …He’s going to ask questions.” 
 
Given reservations about the possibility of covert use, several respondents voiced their doubt, 
ambivalence, and even fearfulness about the potential negative repercussions of both suggesting 
microbicide use, as well as being discovered using a microbicide covertly. Several female FGD 
participants feared that suggesting microbicide use to male partners could introduce or exacerbate friction 
among couples where there already was mistrust; it could also introduce suspicion or lead to accusations 
from men, such as being blamed for male impotency. Women also discussed fears of abandonment and 
mistrust as a result of microbicide use, especially if men were to equate the “wetness” resulting from 
microbicide use with infidelity. 
 
Echoing women’s concerns, national and provincial policy makers and key policy influentials discussed 
the possibility of conflict, abandonment, or violence. As a national policy maker noted, “You’d be kicked 
out of the house if the other party realized you’re using something.”  
 
A female FGD participant suggested that a woman could still use it covertly, even if the man detected 
something, because she could deny the product’s intended function or attribute lubrication to other 
factors. 
“For instance, we do use things like vaginal tubes (suppositories) and they know it. One 
could simply say it's to clean oneself and they wouldn't have a problem.” 
—Woman (26-45 years), homeowner 
 
3. Implications of local sexual and intravaginal practices  
 
A woman’s comfort with the use of microbicides and her perceptions of the feasibility and potential 
ramifications of microbicide use are likely to be informed by her experience with intravaginal products as 
well as sexual practices and cultural norms. The fact that a woman must insert the product in her vagina 
and the potential impact of microbicides on sexual relations were cited as potential barriers to microbicide 
use. Respondents were thus asked directly about intravaginal product use, also probing for information on 
sexual practices, norms and beliefs that might influence the use of microbicides.  
 
a. Intravaginal product use 
 
There were wide-ranging and contradictory views about women’s experience and comfort with using 
vaginal products. Women in focus groups spoke about their familiarity with vaginal products and felt 
comfortable with the idea of using a vaginal product. Most women and several providers stated that 
women were already using tampons and vaginal creams for thrush. 
“We won't be against it because we are already used to using ointments. Men would see 
it otherwise. They're not even bothered in using lotions, and with us we are already used 
to such even with vaginal thrush for instance, we sometimes request getting the cream as 
opposed to pills due to its fast effectiveness.” 
—Woman (26-45 years), renter 
 
When asked if women would be comfortable using a vaginal method, some providers and several policy 
makers gave conflicting answers. A provincial policy influential noted that women already use a number 
of lubricants or vaginal methods and a microbicide would not be “foreign” or “seem very scary.” 
Providers from both the public and private sectors supported this view. However, a provincial key policy 
influential felt that methods requiring vaginal insertion would be problematic and that women sometimes 
delay treatment for thrush because vaginal methods are not attractive. A key informant from an NGO 
concurred by stating that women are not comfortable with “inserting things into their vaginas.” Another 
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skeptical reaction came from a policy maker in the field of HIV/AIDS, who said that, in her experience, 
women were reluctant to insert creams into their vaginas. Despite this, she still felt that the microbicide 
would be important in its potential to offer women more choices.  
 
b. Wetness and “dry sex” 
 
Respondents at all levels discussed at length the effect of “wetness” on microbicide use and sexual 
practices. The concept of “wetness” generally was mentioned in relation to the added moisture that the 
microbicide could present during sexual intercourse. This was discussed, for the most part, with three 
levels of meaning: a) a woman’s vaginal wetness implying infidelity (i.e. she had been with another man), 
b) the preference of men for a “not wet” or “dry” vagina for increased sexual pleasure, and c) the 
association of “wetness” with sexually transmitted infections (STIs).  
 
Given popular assumptions about vaginal lubrication and its association with disease and/or infidelity, 
several policy influentials suggested that the introduction of microbicides should be accompanied by 
awareness programs about women’s anatomy and natural lubrication so that women could better address 
accusations associated with increased vaginal lubrication. One nurse spoke of the need to address 
potential client concerns about wetness and lubrication during counseling. She predicted, “Some people 
would come and say, ‘My boyfriends are complaining that I’m wet using that gel.’” 
 
These concerns about “wetness” were often discussed by policy makers, policy influentials, providers, 
and some community focus group participants by referencing their experience with negative reactions to 
the wetness caused by hormonal contraceptives. A national policy maker mentioned that while the 
medical community had played down these side effects, women frequently complained of changes in 
vaginal lubrication associated with contraceptive use and their partners’ responses to these changes. In a 
focus group of nurses, several participants also reported that women often express concerns with the 
vaginal wetness associated with injectable contraception.  
 
Infidelity 
Study respondents, both male and female, most often equated being wet before intercourse (described as 
ubumanzi in Xhosa), with infidelity and “sleeping around.” The mistrust that could ensue was mentioned 
by men and of particular concern to women in focus groups. 
“I know there is foreplay before one gets sexually aroused. Now this gel gets put inside 
and there could be some misunderstanding when the man finds the vagina wet already. 
This would create mistrust and one would think his partner had sex with someone else.”  
—Male taverner  
 
While men spoke about natural wetness due to foreplay and sexual arousal, they were concerned that it 
would be difficult to distinguish whether a woman was wet due to the microbicide or wet due to having 
had sex previously with another man. Male focus group participants conveyed their concerns and sense of 
mistrust related to wetness, despite acknowledgement that a woman might be wet due to sexual arousal. 
“Men have certain tendencies which could result to them not being interested in this 
method used by women. Men always have priorities when coming to sex. We know that 
women’s vaginas are always moist. There are men who could get put off by the fact that 
it’s wet and think they had sex with someone else. As much as we are aware that when a 
woman feels pleasure sexually she gets wet, so the gel could make a woman even wet 
[ter].” 
—Man (26-45 years), homeowner 
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Women in focus groups also were concerned that their male partners might interpret the presence of 
added wetness due to the microbicide as a sign of infidelity or promiscuity. For instance, one woman 
expressed anxiety:  
“When he arrives he will find that you are already wet and think that you’ve already slept 
with another man, causing arguments.” 
—Female taverner 
 
Sexual pleasure and “dry sex” 
Although in southern Africa a preference for dry sex to increase sexual pleasure has been reported, 2,3,11 
most focus group participants were not familiar with the practice of dry sex as defined by the insertion of 
various drying agents into the vagina before sexual intercourse.* Similarly, most policy makers and key 
policy influentials and some providers were unsure whether the practice of “dry sex” was widespread in 
South Africa or admitted they were not well informed about the issue. One public health doctor stated that 
he had read and heard about the practice but never had a client who reported using any drying agents. 
National policy makers felt that, although “dry sex” may not be an issue among teenagers, “myths” about 
the “dry issue” are “rife” among youths and adolescents.  
 
Nevertheless, community key informants and women in focus groups did speak about men’s preferences 
for the vagina to be dry or “not wet” during sexual intercourse, implying that wetness associated with 
microbicides could be perceived as negatively affecting sexual pleasure. Women indicated that men 
preferred them to be dry and tight “like a virgin.” 
 
A female homeowner suggested that microbicide developers needed to come out with a method that was 
tailored to men’s sexual preferences and suggested a method that was “similar to a face cream and that 
evaporated quickly” so as not to increase wetness. The amount of microbicide to be used was of 
significance within the context of wet sex. Young women from the informal settlement spoke about using 
small amounts of the microbicide to avoid additional wetness and the associated problems with being too 
wet. They spoke about inserting specific amounts of the substance, just enough “to form a wall,” but not 
too much to cause one to be “too wet and slippery.”  
 
Despite notions of men’s preference for a dry vagina, some respondents indicated that women might 
welcome “wetness.” A provincial policy influential felt increased lubrication may be advantageous and 
attractive for sex workers as they frequently experience vaginal dryness. A participant in a focus group of 
nurses also felt that women who experience vaginal dryness when using certain contraceptives also might 
find microbicides attractive. Some women complained that men were not always sensitive to their needs 
with their preference for “dry” sex.  
 
A young woman poignantly pointed out that the issue of wetness was ultimately secondary, and that it 
was not about “dry sex or wet sex, but about safe sex.” 
 
Wetness and STIs 
Several providers, policy-level respondents, and community members also referred to “wetness” in 
association with STIs. One policy maker stated that many youth associate wetness or “discharge” with 
infidelity or disease. Similar to associations with infidelity, wetness as a symptom of an STI was 
negatively perceived by most respondents, including some community members who were interested in 
understanding if one could differentiate between discharge and wetness as a result of microbicide use. A 
nurse discussed the importance of informing clients about the degree of lubrication or wetness to be 
                                                 
* These findings are consistent with another study on intravaginal practices in Khayelitsha, Cape Town, a large 
township not too dissimilar to Langa. In this study, dry sex was rarely reported at only 1 percent. (Myers, Denny et 
al., 2003). 
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expected from microbicide use and explaining the difference between “normal discharge” and heavy 
itchy discharge, indicative of possible STIs.  
 
4.   Product characteristic preferences 
 
Study respondents discussed a range of possible microbicide characteristics that they would consider 
positive or negative. Despite great variation in personal preferences, most participants believed that 
regardless of eventual product characteristics, there would be a considerable market and need for the 
product.  
 
In terms of physical properties, most of the characteristics discussed below emerged as questions or in the 
course of discussion about the product’s potential uses. Among the physical properties discussed were 
smell, messiness, stability of the product for storage, duration of effectiveness, and the product’s 
adherence to the body in relation to bodily functions. Some participants also discussed the design of the 
applicator, mode of delivery of the product, and effectiveness in preventing other STIs and pregnancy.  
 
a. Physical properties  
 
Both men and women in focus groups spoke about a range of preferred microbicide physical properties, 
related to texture, color, and smell. Some felt that an unpleasant smell would be unacceptable and would 
discourage people from using the microbicide. Many were concerned with the texture or “messiness” of 
the product, suggesting that the product should not be too greasy or too liquid in its consistency. One 
provider wanted to confirm that microbicides could safely be used along with condoms, without having 
“an effect on the lubrication of the condom.” A national policy maker was one of few participants who 
noted that ideally microbicides should quickly reach body temperature in order to most resemble a 
woman’s natural lubrication.   
 
As noted when discussing the potential uses of microbicides in case of rape or unplanned consensual sex, 
duration of effectiveness and time to effectiveness were discussed at length in all respondent groups. 
Numerous reasons were also given for wanting the method to last for long periods of time. Women in 
focus groups suggested that the microbicide should last for 24 hours and form part of their daily routine. 
Similarly, a group of young men envisioned a microbicide that would be as easy to use as a “roll-on [an 
underarm deodorant] that lasts from when it’s applied in the morning,” and where “it stays dry all the 
time, because if it causes wetness, it will make one lose interest during intercourse.” Some community 
women indicated that microbicides should be like the contraceptive injection, which is administered every 
two to three months.*  
 
Most policy makers and providers also felt that microbicides should be both quickly effective and long 
acting. A provincial policy maker suggested it would be preferable if microbicides were effective for 
multiple sex acts. However, several respondents in a focus group of nurses suggested it might be better if 
microbicides were only inserted immediately before sex and then washed off afterward to avoid “being 
wet or causing skin irritations.” One national policy maker was concerned that if it was effective for an 
extended period of time it might “start interfering with the normal function of the body.” 
 
The importance of product stability was mentioned by several policy makers and providers. They 
indicated that microbicides should be stable at a variety of temperatures and should not require 
                                                 
* It is not surprising that participants likened the duration of action to contraceptives, a familiar reference point, as 
contraceptives form an important part of women’s reproductive experiences. Three-quarters of South African 
women aged 15 to 49 have used a contraceptive method, and 61 percent of sexually active 15- to 49-year-olds 
currently use some form of contraception. 
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refrigeration. Additionally, both male and female focus group participants raised questions about how 
well the product would adhere to the body and what happened to the product after it was inserted. This in 
turn was linked to everyday bodily functions such as washing and urinating. One woman asked, “How 
does it come out, does one have to urinate to get rid of it?” Similarly, a group of men from the informal 
settlement were particularly concerned as to what would happen before and after urinating, and if women 
could use the method while they were menstruating. Lengthy conversations ensued around how urination 
could influence the method’s effectiveness. Men felt they needed assurance that the method would not be 
removed during urination. 
 
b. Applicator and mode of delivery 
 
Similar to other characteristics already discussed, some participants had varying views on how 
microbicides should be delivered into the vagina. Since focus group facilitators and interviewers showed 
focus group participants and interview respondents an applicator similar to that currently used for 
Carraguard , most participants who commented on this issue reacted to this applicator, with some 
suggesting alternative modes of delivery.  
 
Some women in focus groups expressed concern about the shape and phallic appearance of the applicator 
and felt that it was “too sharp” and would be painful and difficult to insert.* One focus group participant 
commented:  
“It's not attractive to look at it. Honestly, even if one doesn't mind sex and a penis, it 
looks like the shape of a penis, it does, and it doesn't interest me at all. One other thing, 
it's made for women, its shape gives one the impression that women want sex all the 
time.” 
—Woman (18-25 years), renter 
 
They also suggested that it should be designed differently, “similar to the suppository” or like a tampon. 
Nurses in the public health sector and several provincial and national policy makers had similar 
suggestions and felt that the applicator should be “friendly to the user.” A national policy influential felt 
the applicator looked like a “clinical gadget. It’s frightening.”  Another looked at a sample microbicide 
applicator and said:  
“This looks like a horrific gadget, but it certainly looks like a piece of medicine.” 
  —National policy influential 
 
The actual mode of delivery became a topic of detailed discussion as female focus group participants 
suggested different mechanisms of administration, such as a pessary or suppository versus an applicator, 
or oral ingestion. In another discussion group with nurses, one participant stressed that it should be easy 
to insert whether a woman lies down or lifts up one leg. Another doctor who commented on the issues 
recommended that the applicator should be for a single dose rather than a tube or multi-use applicator that 
could potentially be shared by multiple women, thereby creating a risk for infection.  
 
c. Scope of protection: HIV, other STIs, and pregnancy 
 
Some microbicides may have contraceptive properties or offer protection against other STIs, while others 
may not. Policy leaders, providers, and community-level respondents differed in their views on the scope 
of protection that they would like microbicides to have. Some were able to clearly separate the issues of 
HIV/STI prevention and pregnancy prevention, while others saw them as inextricable. 
 
                                                 
* It should be noted that the edges of this applicator are not sharp, and that respondents are referring to the pointy 
shape of the applicator. See photo on page 15. 
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Community members had mixed reactions to the desirability of contraceptive properties. Women tended 
to prefer that microbicides not be contraceptive, while more men preferred that microbicides would have 
contraceptive properties. One male taverner said: 
“If you want her to fall pregnant, then you discuss with her not to use it. Because should I 
meet someone at a party and sleep with her, and then she comes to my home the 
following week to say she’s pregnant.” 
—Male taverner 
 
Another added that having to worry about dual methods would be too complicated. “I don’t want to use a 
condom [and] I still don’t want her to fall pregnant when she’s using this gel.” However, some men 
recognized that women would not want a microbicide to prevent pregnancy.  For example, a young man 
felt that women would find a non-contraceptive microbicide more attractive as “they enjoy falling 
pregnant.” Some men also preferred a non-contraceptive. 
“[It’s] very important with regards to preventing disease. If it will prevent pregnancy as 
well and make us not have children, it won’t be appropriate.” 
—Man (26-45), informal settlement 
 
Provider experiences with managing and treating large numbers of people with HIV and other STIs 
shaped their perceptions of the most pressing and immediate prevention needs; they tended to see 
contraceptive needs and disease prevention needs as two separate issues. Several providers were not 
convinced of the need to have a microbicide with contraceptive properties given the existence of other 
contraceptive options. When asked, “What sort of advice would you give a client in relation to 
contraception if microbicides do not prevent pregnancy?”, a few providers even appeared confused by 
the association of contraceptives and microbicides. One doctor responded by asking, “Is this a trick 
question?” The provider then went on to elaborate that she did not foresee a problem as long as the 
microbicide did not react with a woman’s regular contraceptive method. Only a few providers felt that 
dual-protection characteristics of microbicides would be advantageous in the sense that they could 
facilitate consistent and ongoing use.  
 
Provincial and national policy makers and providers seemed ambivalent about recommending 
microbicides for pregnancy prevention if they were proven only partially effective.* One private doctor 
said he would recommend it to his clients for both purposes if the contraceptive effectiveness of 
microbicides equaled that shown by other methods, such as injectables. Several policy makers felt that a 
microbicide with dual protection properties (HIV/STIs and pregnancy) would be a beneficial addition to 
family planning programs. One national policy maker explained that one reason it would be advantageous 
was the difficulty of motivating clients to use both condoms and injectable contraceptives.  
 
Given the immediacy of the HIV/AIDS epidemic and the current availability of acceptable and effective 
contraceptive methods, several respondents felt it would not be necessary for microbicides to provide 
protection against both pregnancy and HIV. One national policy influential felt that, while it would be 
ideal for a microbicide to prevent pregnancy, finding a barrier to HIV “is a priority” and should be 
addressed first.  
 
By contrast, a few policy makers felt that clients may not find a microbicide that prevents pregnancy more 
attractive. A representative from a nongovernmental organization suggested that among certain sections 
of the population, particularly sex workers, there was a particular need for HIV prevention rather than 
pregnancy prevention measures. Another national director suggested that the availability of both 
                                                 
* Providers were not told that microbicides would be partially effective as contraceptives—they assumed this would 
be the case since first-generation products are likely to be partially effective for HIV prevention. 
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contraceptive and non-contraceptive microbicides could lead to confusion and discord among women and 
their partners.  
 
d. Infertility concerns 
 
Both men and women in focus groups were concerned about a microbicide’s possible short-term and 
long-term impact on fertility and child bearing. These concerns emerged spontaneously as respondents’ 
explored possible side-effects from microbicides. Women ascribed male partners’ and other women’s 
possible reluctance to use microbicides to a fear or belief that it would have a negative impact on fertility. 
One woman stated, “Our fear would be the side effects, like making one unable to bear children.” Many 
men were equally concerned that the microbicide might impact on fertility and a woman’s ability to bear 
children. These concerns were not surprising considering the importance placed on child bearing in many 
communities.  
 
Women and men were also concerned about the possibility of infertility associated with frequent 
microbicide use. Indeed, several community members pointed out that microbicide use might be falsely 
associated with infertility. A young woman from the informal settlement suggested a married woman 
using microbicides might be accused of being infertile if she did not become pregnant, and other women 
from this area and young women renters echoed these concerns and vividly described the social cost of 
infertility: “And [when] one can’t have children, then we are chased away.”  
 
In the event that microbicides did not prevent pregnancy, both men and women expressed concern about 
the effect of microbicide use on fetal health. A key informant and some community members felt that 
microbicides should not only be safe to the user, but also should not harm the fetus.  
 
 
D. FINDINGS RELEVANT TO SERVICE DELIVERY 
 
The research addressed several issues related to microbicide introduction with important implications for 
service delivery programs and providers. Respondents discussed the challenges of meeting counseling 
needs with a partially-effective, user-controlled product, and approaches to ensuring informed choice. 
They also addressed how microbicides might fit into the current mix of HIV prevention methods, and 
considerations for presenting microbicides within a hierarchy of prevention options. Finally, discussions 
focused on channels through which microbicides might be distributed in both clinical and non-clinical 
settings, including approaches to ensuring adequate information and counseling while promoting broad 
access and choice. 
 
Perceptions of policy makers and key policy influentials, and to a lesser extent providers and community 
members, were shaped by their previous experiences with the introduction of reproductive health 
innovations. Alluding to experience with introduction of technologies like the female condom and 
programs such as prevention of mother-to-child transmission (PMTCT), providers in particular 
emphasized the value of early involvement and information before offering any new product or approach. 
 “Clinics and health providers need to be informed before the product hits the market. I 
think that's what people like—I think first of all, rather than waiting until we get circulars 
coming around, but it doesn't have the same effect if we have somebody in front of you 
and showing you, this is the product, this is the use, and this how we're planning to do 
it… and that information is available. It makes it so much easier.”  
—Public health doctor 
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1.   Counseling and informed choice 
 
Counseling was considered an important element in ensuring that potential users are knowledgeable about 
product use and fully aware of the implications of partial effectiveness so that they can make informed 
choices. Policy makers and providers discussed a range of complex issues related to presenting 
microbicides in the context of an HIV risk-reduction approach.  
 
Almost unanimously, policy makers and policy influentials felt that clients should be informed about the 
safety, effectiveness, contraindications, and side effects—information considered essential for a woman to 
make an informed choice about whether or not to use microbicides. One policy influential stressed that 
only with a full understanding of partial effectiveness can women make informed decisions. A policy 
maker spoke of the importance of “full disclosure” in presenting options. As such, many providers and 
most policy makers supported offering the option of microbicides among a broader range of prevention 
methods, with the belief that greater choice would reinforce prevention and decrease the incidence of HIV 
transmission to save lives. However, a few providers talked about the importance of choice, then went on 
to state that they would only be willing to offer clients the option of microbicides if they believed it to be 
appropriate, suggesting that informed choice did not have the same meaning for all providers.  
 
Community members also asserted that they would need extensive information and education about 
microbicides. One community member interviewed, for example, said that users “will need to be educated 
first, and be given lessons on how to use it…I’d never use something with no clear explanation. It’s 
important that I get taught about it, truly speaking.” Another, a male focus group participant, emphasized 
this need in the recognition of the difficulty in making changes related to sexual practices. 
“It’s not a matter of getting used to something overnight when it comes to sexuality…It 
means I’ll forget one day, but the following morning I’ll wake up and realize. That’s why 
I say the most important thing is to train people.” 
—Man (26-45), homeowner  
 
When asked who should provide the necessary information, respondents at all levels repeatedly 
mentioned health care providers, community health workers, or people specially designated as 
“counselors.” However, as many providers recognized, identifying who in a particular clinic should 
provide counseling can be difficult. A public health physician noted that, ideally, health providers in large 
clinics who deal with sexually transmitted infections should be responsible for introducing microbicides, 
while another public health physician felt that designated counselors should be hired at respective 
facilities to “take the pressure off the provider.”  
 
While aware of the value of counseling, several providers also were acutely aware of the difficulties of 
providing quality service, particularly in the public sector. In a focus group, nurses mentioned that clinics 
are often crowded and providers pressed for time.  
 “My problem is I wish I had more time to do what I’m doing. There’s no time to sit with a 
patient. Language is a problem. If I have an interpreter sitting with me, maybe we can do 
much more. We don’t have that here; we don’t have enough staff for that.” 
—Public health physician 
 
Given these difficulties, providers and policy makers stressed the need for provider training and regular 
updates. One physician suggested that everyone in the health clinic, not just physicians, should be trained 
in order to increase the impact of the intervention. A provincial policy maker stressed the importance of 
also involving community health workers in training so that may provide good counseling for their 
clients.   
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A few respondents also saw community leaders playing a role in delivering counseling and accurate 
information to potential users. A community member interviewed initially agreed that health care 
providers should be the ones to do counseling, stating that “professionals are good even in explaining 
when one has never heard of it, for instance…” She later acknowledged that lay people could play a role, 
stating, “I’d like it to be handled by pastors in churches, because they are faithful people. Female pastors 
would be better …they will be able to express themselves easily to other ladies.”  
 
a. Counseling messages and approaches 
 
Again, policy makers’ experience with other technologies, particularly the female condom, informed their 
understanding of the kind of counseling necessary for microbicide introduction. One policy influential 
stressed that good communication and counseling were both the greatest challenge to and the measure of 
success of introducing new health innovations such as microbicides. In addition to information on safety 
and side effects, respondents also mentioned that counseling should include information about how 
microbicides work and how microbicides might influence women’s fertility. Policy makers also felt that 
counseling should address more general issues about women’s sexuality and anatomy, including the 
changes of lubrication in a woman’s vagina associated with use of microbicides to help minimize 
allegations of infidelity associated with an increase in lubrication or wetness.  
 
Several policy makers mentioned the need to include men in counseling programs. A journalist said that 
educating men would help to create an enabling environment for their partner or partners to use the 
microbicide. It was also suggested that women need counseling on partner communication and how to 
negotiate microbicide use. In the words of a national policy maker in the public sector: 
 “Even if microbicides are coming, we need to empower women in terms of their 
negotiating skills, you know, for them to be able to start talking to their partners because 
this has come up several times with the female condom … It’s basically initiating 
communication, you know, to say that the act needs two people, it takes two to tango, for 
them to start talking about it.” 
—National policy influential 
 
A private physician highlighted the difficulties in conveying complex ideas about prevention, particularly 
given his clients’ limited knowledge of the concepts of germs or infection. He stressed the need to keep 
messages concise and “simple.” A provincial director of a nongovernmental organization underscored the 
effort involved in crafting creative and effective counseling messages.   
“You know, not just sort of assume or write it on a piece of paper and think that 
someone’s going to understand it, you know, and obviously finding better words, like 
efficacy would be a bit {pause} just something that would make people feel clear in terms 
of what it is and what it is providing.” 
—National policy influential 
 
b. User-controlled methods 
 
One issue that emerged in the context of counseling needs and informed choice was concern over the 
user-controlled nature of microbicides, and the implications for consistency of use and continuation.  
Consistent with the doubts that providers often have about user-controlled contraceptive methods (such as 
condoms and other barrier methods and oral contraceptives), some providers interviewed emphasized 
their concerns that microbicides would not be highly effective in preventing disease transmission due to 
the possibility of discontinuation. When asked about the perceived disadvantages of microbicides, one 
provider responded, “The disadvantage would be the possibility of stopping the method.” Other providers  
were concerned about the dosage and frequency of application, suggesting a lower likelihood of  
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compliance with a user-controlled microbicide that required more frequent application. One private 
physician noted: 
 “If it’s a monthly thing that needs to be taken, it’s fine. You know once a month, but if it’s 
a daily thing or three times a week, they’re not going to be very compliant.”  
—Private doctor 
 
Providers indicated that consistent use would depend on the nature of associated side effects, noting that it 
would be pointless to expect consistent use with microbicides if they had serious side effects. 
Nonetheless, some providers spoke about how newly introduced products also face the burden of having 
to live up to client and provider expectations, and that criticism of new methods was not uncommon. 
 “Everything that is new is going to be criticized or it's not acceptable initially. It takes 
time because initially people wouldn't even think of the condom but now gradually for 
those that feel – know that, they can see that HIV/AIDS kills, they'll use it.” 
—Nurse 
 
To overcome this perceived resistance to microbicides and to facilitate ongoing and consistent use, policy 
makers and providers emphasized the importance of comprehensive counseling and support, and equally 
their own need for support, including information and training so they can better meet the prevention 
needs of their clients.   
 
2. Integration into the hierarchy of prevention options and method mix  
 
Male and female condoms are frequently offered as part of a hierarchy of options that could help prevent 
HIV infection. For almost all providers, the concept of a prevention hierarchy or the relationship of 
microbicides to existing prevention methods and strategies emerged naturally during interviews and 
discussions. However, the views of providers and policy makers on how microbicides should be 
integrated into the existing method hierarchy varied. The majority of respondents emphasized that while 
microbicides were not the ideal product, they could complement existing, albeit limited, prevention 
options to reduce individual and community HIV infection rates. 
 
Many providers and policy makers were enthusiastic and supportive of having alternative options;  
however, given microbicides’ partial effectiveness, they were somewhat cautious about how to offer and 
position microbicides in relation to other prevention options so as to discourage or limit condom 
substitution.   
“People want to get a product that they believe is going to protect them … it's like you 
say, this is a method, it's not completely safe (i.e. effective) on its own, you have to use it 
with a condom, you know? … people might think well, if I have to use this and the 
condom then like what's the - you know, why am I using it?” 
—Provincial policy influential 
 
A public health doctor stressed that while microbicides could be offered as an “extra weapon,” the 
condom should still be considered the “health standard.” Another advocated for offering microbicides, 
but only as a “complementary” to condoms, suggesting that dual methods—condoms and microbicides—
should be the approach. 
“… I think the hard and fast rule is use a condom at all costs. I mean whether you are 
using anything else (or not).” 
—Private doctor 
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Other providers and policy makers recognized the cumulative risk reduction benefit of offering 
microbicides, even as stand-alone product.  
“I think part of your challenge is that the a, b, c approach is so linear or exclusive. It is abstain 
or be faithful or ‘condomise’ and I think that your communication needs to be structured so much 
more around risk reduction, overall risk reduction, and get people to understand the marginal 
benefit of a condom, the marginal benefit of using a microbicide and the cumulative risk 
reduction of multiple risk reduction strategies.” 
—National policy influential 
 
Many policy makers and providers felt the products should be offered, but positioned together with the 
male and/or female condom, even if people choose to use microbicides alone, in an effort to continue 
promoting the most effective method but also to provide multiple options and reduce risk overall.   
“So I think maybe you should—you can develop other methods and at the same time 
devise other ways of making sure that people know the condom is still the best. I think 
you can’t only have the one and think that you’re going to be okay.” 
—Provincial policy influential 
 
A policy maker argued that informed choices and advocating for risk reduction messages were ideal but 
may not be realistic in the context of an overburdened health system. Sharing the views of other policy 
makers and some providers, a provincial policy maker was reluctant to predict that microbicides could be 
easily integrated into the spectrum of prevention methods without efforts to overcome provider biases 
against what would be perceived as an imperfect and complex method to offer.  
 “I guess [the] major obstacle against or blocking is general health workers…You have to 
kind of convince a health worker that it’s going to be worth the effort to try and actually 
do something, where we have condoms and it’s just easier. It’s easier for [them] seeing 
100 people a day to promote condoms. [As a health worker] why should I diversify my 
message and introduce something which could be effective, is not effective, could have 
side effects, can’t guarantee it?” 
—Provincial policy influential 
 
3. Distribution channels  
 
Study respondents and focus group participants at all levels discussed a range of potential distribution 
channels for microbicides.  In recognition of the idea that products and services may be delivered outside 
of the clinical setting, and that the clinical setting may not be ideal for facilitating access, researchers 
probed for ideas about how microbicides could be delivered in a range of settings under varying 
conditions.   
 
a. Potential avenues/venues for introduction and distribution  
 
Community members, policy leaders, and providers articulated the need to balance a desire for 
widespread access to microbicides with the need for relatively complex prevention messages. While most 
respondents felt microbicides should be widely available, many also hesitated to endorse the distribution 
of these products in venues where personal counseling was not available, given the partial effectiveness of 
these products. There was also concern about ensuring the quality and safety of microbicide products 
when purchased in the non-health commercial sector. 
 
Health facilities were most often named as the ideal venues for distribution. A young woman from the 
informal settlement felt microbicides should be available at clinics because “that’s where we go mostly 
for such things and that’s also where we get our contraceptives.” The director of a national NGO agreed 
that microbicides should be available in the government health sector because women already went there 
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for maternity and well-baby services, and providers also felt that microbicides should be available at 
health facilities. A public health manager suggested that microbicides should be available in family 
planning, maternal health, and VCT clinics because family planning clinics already offer comprehensive 
services, and a private physician felt that they should be available at local clinics, day hospitals, and GPs 
“because those are the people who see most clients.”  
 
A number of respondents suggested potential problems associated with distributing the product in the 
public health sector. If microbicides were distributed at public health clinics, for example, they would be 
associated with disease rather than health. In a few community focus groups, participants expressed 
suspicion that even if microbicides were to be distributed in the public sector, they might not be available 
to clients because the health service providers would take microbicides for themselves and “tell you it’s 
finished with a ‘for sale’ sign outside.” Others noted poor treatment by nurses as barriers to access.  
Building on this concern about the limitations of the public health service, a private physician mentioned 
that microbicides should be available wholesale for private physicians because there may be shortages in 
the public sector.   
 
Finally, noting that people are not always comfortable in health service environments, one policy leader 
underscored that:  
“[You need to] get a person that they can relate to, that they can feel comfortable talking 
about issues… If you allow service providers to be the main entrance for the product, I 
think you limit the chances of it being more effective. 
—National policy influential 
 
Building on this, a variety of additional venues accessible to both men and women were proposed by 
respondents at all levels: community-based organizations; chemists, supermarkets, and outlets at which 
herbal medicines are obtained; and at spazas (local informal shops) and shebeens (bars), particularly for 
men since they do not visit health facilities frequently. A woman in a focus group felt products should be 
found in “places we can reach without using public transport because clinics get closed … A place that 
everybody can reach.” Several men and women also mentioned that microbicides could be distributed 
like condoms, through vending machines located in toilets, schools, taxi stands, or transportation hubs. 
Experience with condom social marketing led a representative from a national NGO to conclude that 
public clinics, supermarkets, and chemists would not be the best places to reach youth because the 40 
percent of young, sexually active people cannot access them at these places. Rather, the “best place would 
be the mama sitting at the entrance to school with her vetkoek [doughnuts]. That would be the best 
place.” Some community respondents also felt it would be possible to distribute microbicides at schools 
so that children could take them home to their parents. That said, several community members noted 
concerns about the quality of products procured from certain commercial locations. The most common of 
these concerns was the potential of receiving a product that was too old, had been tampered with, or was 
not of good quality. For example, several community members did not feel spazas were “clean” or that 
their proprietors likely to maintain an up-to-date stock. 
 
Providers also had concerns about microbicides being provided in dispensers without any formal 
counseling, especially given partial effectiveness, and suggested that microbicides should be introduced 
first in the health services, “and then as soon as people accept the product like the condom, then we can 
start...so it is easily available.”  
 
While many policy makers and key policy influentials generally endorsed the idea of distributing 
microbicides in public facilities and beyond, they also warned of the financial and logistical difficulties of 
introducing something new in the public sector, and expressed concerns about ensuring a reliable and 
affordable supply. Several policy makers and community members interviewed stressed the need for a 
comprehensive introduction strategy that includes government departments both inside and outside the 
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health sector. Another key policy influential stressed the need for the public and private sector to work 
together. In the words of a community health worker, introduction must be approached “from all angles,” 
including labor unions and health and non-health organizations, in order to “counter the fear of the 
unknown.”  
 
b.    Assuring sustainability of supply 
 
The experience of policy makers, key policy influentials, and providers with the introduction of other 
reproductive health technologies clearly colored their ideas about the pace and form of microbicide 
introduction. Respondents from both the public health sector and nongovernmental organizations spoke at 
length about their experience with the female condom, in which expectations for the product were raised 
within communities and there was not a sustainable supply to meet that demand. Several respondents 
recognized the difficult balance between the need to market and create demand before introducing 
microbicides, and the importance of systems to meet the demand that is created.   
 “We have done very well in terms of creating a demand, but in a lot of instances for a 
number of years we didn’t make the products easily available. Classical example is the 
female condoms. We created a hype and when people rushed to get the products, what 
did they see? ‘No, they are not available.’” 
—National policy influential 
 
Partly to help avoid these problems, several provincial and national key policy influentials suggested 
gradual introduction by marketing microbicides first in pilot sites in both the public and private sectors 
and via nongovernmental and community based organizations. 
   
One provider attributed shortages to “erratic supplies” and was concerned about promoting microbicides 
without some guarantee that they would be sustainable in both cost and supply. Based on experiences 
with condom distribution, one policy maker described the effect of stock shortages on access: “We have 
to wait for the next lot of shipments to arrive, and then you sit for three months without condoms.” Such 
shortages were considered very problematic, particularly early in an introduction process. 
 
 
E. FINDINGS RELEVANT TO POLICY DEVELOPMENT AND 
ADVOCACY 
  
A range of issues with implications for microbicide policy development and advocacy emerged from this 
study. One key issue relevant to policy and advocacy was the need for information for policy makers, 
providers, and potential users. Recognizing that the provision and dissemination of information are 
crucial components of any introduction strategy, respondents at all three levels of inquiry described the 
types of information that would be important for making a decision about the introduction or use of 
microbicides. Respondents also raised concerns and offered opinions about challenges related to the cost 
of microbicides: the cost to the system of introducing the product and the cost to the consumer. Finally, 
they offered insights on effective approaches to product positioning and marketing.   
 
1.   Information needs 
 
Policy makers emphasized that they would want access to results from both animal and human clinical 
studies to determine whether microbicides were safe and effective and to develop a clinical protocol and 
recommendations for providers. A national policy influential and several focus group participants 
requested information on the results of completed clinical trials and ongoing trials being conducted in 
South Africa. Publication of both types of information in respected journals would be important in 
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helping to allay the fears, mistrust, and misinformation associated with the AIDS epidemic generally and, 
more specifically, new medical technologies such as anti-retroviral drugs or microbicides. He stressed 
that information about on-going trials might help to ensure that it is “not so much of a surprise when the 
product is eventually registered and approved for use.”   
 
Men and women in community focus group discussions were also interested in knowing, and in some 
cases seeing, evidence as to whether microbicides were “successful.” In a group of taverners, several men 
were afraid that people would begin using microbicides only to learn that they were ineffective. Several 
respondents underscored the importance of hearing from trusted and credible people, one respondent 
suggesting that it would be useful to bring a person who had personally used the microbicide to testify to 
its effectiveness. Another respondent stressed that, “It’s important that a black person explains to another 
black person as opposed to a white person.” One man stated, “Not having enough information on the 
method could cause fear.” 
 
National policy makers suggested that clients would also want to know if microbicides could prevent 
pregnancy, how long they would be effective once applied, and what to do both before and after 
intercourse. They also said that, before they recommended widespread use of microbicides, they would 
want evidence that microbicide use would not lead to a decrease in condom use or undermine the condom 
program. 
 
Community respondents were quite explicit about the types of information they would like to have about 
microbicides: women would want to know how to apply it, how long it lasted, whether one needed to 
reapply after washing, and whether it prevents pregnancy. Lack of information could cause their partners 
to believe that the gel could give them infections, and men might also be suspicious if they did not know 
that microbicides would be for their protection as well. Male community members were most interested in 
how much microbicides would cost, how long in advance a product could be applied, whether one could 
wash or urinate while using a microbicide, and whether it was “suitable for all female age groups.” Men 
also wanted to know whether microbicides protected against only HIV or also against other STIs and 
pregnancy, and whether the products would have an expiration date.  
 
Similar to policy makers and community members, providers stressed the need to offer potential users 
detailed information about how microbicides work and how effective they are so that women and their 
partners could make informed choices about whether or not to use them. Community health workers 
concurred, and also wanted to be informed about effectiveness, side effects, costs to the client, and 
distribution points to effectively advise users. They also requested counseling guidelines so they could 
understand how this critical information should best be conveyed to clients.  
“The client actually understands,… what one is talking about, whether it’s pregnancy protection, 
whether it’s HIV, STI protection and if there’s any sort of lack of clarity around, then [providers] 
should rather not offer [microbicides] and just stress that the condom is still the health standard. 
You know, this is just an extra weapon.” 
—Public health doctor 
 
a. Sources of information  
 
Both public and private physicians stressed the need for pamphlets or small booklets to detail how to use 
microbicides and to describe any side effects. Some also suggested that posters with simple messages 
were important means of communication. Provincial and national policy makers noted that pamphlets had 
been used in previous HIV/AIDS education efforts with varying levels of effectiveness. One policy maker 
stressed that information should be “people-based rather than pamphlets,” and a journalist suggested 
conducting workshops in people’s own languages.  
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Respondents at all three levels of inquiry, but particularly community participants, stressed that 
individuals providing information often act as advocates for products and may influence acceptance and 
use of microbicides at the community level. In addition to providers, potential advocates included family 
and friends, schools, community leaders, traditional healers, community based organizations, and the 
church. There was a clear call to involve communities, particularly organizations and leaders, in the 
introduction and dissemination of microbicides.  
 
For example, a national policy maker pointed out that young girls in South Africa are often well 
organized and motivated to engage in prevention promotion activities, and youth groups could provide 
useful support. Other policy makers and community members agreed that parents, particularly mothers, 
could also play an important role in influencing their children’s sexual behavior. Others cautioned that not 
all parents were aware of their children’s sexual activity, and others felt that parents could have a negative 
impact if they perceived that microbicides would give children license to become sexually active at an 
early age. 
 
Some policy influentials pointed out that, although some churches oppose condoms, they may not oppose 
microbicides, since condoms prevent pregnancy and microbicides may not. Churches have been involved 
with and provided support for people living with HIV/AIDS, and many have very active youth programs; 
one policy influential noted that almost 80 percent of young people profess an association with some 
faith-based organization. A nurse also mentioned that youth participate in church-sponsored groups, such 
as choirs, which would offer a good forum for advocacy activities. A community member interviewed 
suggested that if you want people to believe in an idea “and take it to church, they are bound to believe in 
it.” Another national policy maker pointed out that faith-based organizations already provide a substantial 
amount of support for women who are HIV positive and their families, and they could also help advocate 
for microbicide use. From a more practical standpoint, a community health worker noted that priests often 
offer marriage counseling, which could be an important venue for discussing microbicide use in addition 
to other reproductive health issues. 
 
At all three levels of inquiry, respondents felt that the recommendations of health service providers played 
an important, albeit not solitary, role in shaping men and women’s sexual behavior. Several policy makers 
felt that in addition to training clinic-based providers, it would be important to involve community health 
workers and traditional healers in promotion and counseling programs. One national policy influential 
noted that many men and women may visit traditional healers if they have problems associated with 
microbicide use. The key policy influential suggested involving and training traditional healers to serve as 
counselors and advocates, similar to health intervention models against tuberculosis in the Eastern Cape. 
 
2.  Cost 
 
Respondents at all levels were concerned about the cost of microbicides to the consumer. Varying 
opinions were expressed on the pros and cons of providing microbicides free of charge, and on the price 
that consumers might be willing to pay. Policy makers and some providers had substantial concerns about 
the cost to the health system, whether the product was to be provided free of charge or not. 
  
a. Cost to the consumer 
 
National and provincial policy leaders and providers all stressed that microbicides should be accessible to 
clients and provided at low or no cost, or at least be provided free in public facilities.  
 
Two providers based at public health facilities stressed that microbicides needed to be affordable in order 
for them to recommend them or clients to use them on a regular basis. While few providers mentioned a 
specific price, one private provider suggested it should cost less than 30 Rand (approximately $4 US), 
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roughly the average cost of STI treatment. To make microbicides accessible to youth and adolescents, a 
national policy informant felt they should be available at an extremely low cost—perhaps 50 cents (in 
Rand). They looked to government to play a main role in making microbicides accessible, even if they are 
not free, as “it’s the government’s responsibility to look after the people especially in health and work 
related matters.” Some respondents, however, questioned whether the government could afford to 
provide microbicides at low or no cost. Several national and provincial policy makers also stressed that 
microbicides should be priced competitively with condoms or, in some instances, the female condom. In 
the case of the latter, national policy makers recognized that the possibility of repeat use of female 
condoms should also be considered when pricing microbicides.  
 
Contradictory views were raised at the community level about the cost of microbicides, with some 
pointing to the high rates of unemployment as a limitation on people’s capacity to buy the products. 
Others stressed people’s desperation to use some form of protection in light of the high levels of HIV and 
other STIs. Many focus group participants were concerned that if microbicides had to be bought, this 
would exclude access and availability to those who did not work. 
 “If it’s going to be sold then that is wrong. Where are we going to get the money? If it 
costs, let’s say R30 or R50, who has that kind of money? Then they better forget all about 
it and let’s stick to the condom” 
—Male taverner 
 
Many community members said that, although money was scarce, people were desperate and would find 
money to buy the product. One young woman said that, to her, “Price wouldn’t matter as long as there’s 
a guarantee that one wouldn’t get HIV and that it’s got no side effects. I would go for it because my life is 
more important.” Others felt that if a microbicide cost too much some people would not be able to afford 
it. She suggested that it not cost more than 5 Rand “because some don’t work and condoms are free at the 
clinic.” A private doctor pointed out that there’s a problem if the person can afford to try the product but 
not to continue to use it. “Cost is a major thing when you’re working in the townships.”  
 
Discussions at various levels also centered on whether people would consider products distributed at no 
cost as being inferior. Community members pointed out that free methods such as condoms are of 
notoriously poor quality, and that the condoms from public health clinics are not used because people 
perceived them to be “weak,” i.e., not very effective. A participant in a focus group of nurses concurred 
that condoms distributed free in clinics are often popularly perceived to be of inferior quality.  
 
Contrary to the prevalent point of view that microbicides should be low cost or free, some policy makers 
mirrored the perceptions of clients and supported the assertion of social marketers that products 
distributed in the public sector or free-of-charge are seen as inferior to other methods or products. Others 
had very mixed views on whether microbicides should be free or bear some cost.  
“People perceive things to be from the government as negative and going back to the 
apartheid days where people think ‘whatever the government’s giving me is inferior. And 
maybe they’ve got a plan, maybe they just don’t want me to have children’, all of those 
ideas… Also, there’s this thing of where people pay for things they seem to appreciate it 
more and place more value on it…But also you want them to be available to people, you 
don’t want the fact that the person is poor, and they can’t afford it…for me it’s probably 
going to be best to go with something that is free..” 
—National policy influential 
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b. Cost to the health system 
 
Some policy makers expressed concerns about the cost to the health system, the limited resources 
throughout all levels of the health system, and the difficult decisions that must be made among  
competing priorities.   
“We’re sitting on a ridiculous situation that we don’t have enough money for 
vaccines…and cost has become a major factor in terms of what package of health care 
actually gets delivered…if it comes in at a cost, it needs to be located within the 
continuum of what the public sector can afford.” 
—National policy influential 
 
“Effectively, the biggest block to an effective public health service in Cape Town is 
resources, is funds. And it applies from national, to provincial, to local government 
already. I mean Health is not getting an adequate slice of the pie…of course as long as 
we didn’t buy submarines and fighter jets and all that we wouldn’t have this problem…” 
—Provincial policy influential 
 
Other policy makers expressed concern about the level of the health system that would bear the cost, and 
whether officials would be willing to budget for something that may not be highly effective. 
“You just need to get the buy-in from…national, provincial, down the line…and funding 
for it. … If you didn’t—especially if it was costly and if you didn’t additionally fund for 
it—it won’t take off, because everybody’s pressed in their budgets. So nobody’s going to 
say, ‘Well, this might work so I’ll take the chance and send another R1-million on this of 
my district budget.’” 
—Provincial policy influential 
 
While several national and provincial policy makers noted the financial difficulty of providing 
microbicides free in the public sector, one provincial policy maker said that if it was felt to be very 
effective, “Whatever the price is, we’d buy it.”  
 
3.  Product positioning and marketing  
 
Several respondents had very specific ideas about the types of advertising or marketing messages that 
should accompany microbicide introduction. A policy maker at the national level stressed the need to 
“reduce the stigma as much as possible” in order to make the process accessible to everyone. In a similar 
fashion, another national policy maker felt messages should be general and not be directed at “people who 
might be sleeping around.” In order to interest all women in the product the same respondent felt that 
information about microbicides should be given to women’s groups and organizations or advertised in 
women’s magazines.   
 
Another informant suggested messages needed to stress that “it’s cool to use this gel” and for young 
people to make it “hip and happening.” A key policy influential added that it should be positioned as 
“part of a healthy life for trendy people in South Africa.” The respondent felt that microbicides should be 
marketed as “part of the natural process” rather than as a medication. Another national policy maker also 
felt the underlying message should be positive: “We need to … be radical enough to say, ‘People enjoy 
sex so let’s do it properly.’”  
 
A policy influential was very clear that microbicides packaging should not be linked to AIDS.  
“Which person wants to use a condom with an AIDS ribbon it? I mean, that's ridiculous. 
Then you've located it very, very firmly in the realm of a medical tool. I  just wish the 
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government would change their packaging. But it's the same here, don't position this as 
‘This is about AIDS.’ Position it as ‘This is about healthy sexuality.’"   
—Policy influential 
 
In focus groups, many women felt advertising should be directed toward women, with the packaging 
“nice and attractive.” One woman referred to the container for another product that looks “like candy” 
and suggested that this would cause a woman’s partners also to be interested. In a similar vein, 
respondents stressed that the packaging should be similar to other commonly-used female products like 
tampons or suppositories.   
 
In both men’s and women’s focus groups, participants spoke at length about both the packaging and the 
type of applicator. A young man suggested it should be marketed in a container that prevents tampering. 
Another woman in the same focus group stressed that it should be “exciting and relevant to youth” and 
the package easily recognizable on the shelf.  
 
Respondent discussions of the beneficial or positive characteristics of microbicides may hold important 
implications for the marketing or positioning of a future microbicide. However, given that participants 
were discussing a hypothetical product, these findings should be viewed with caution. Nevertheless, both 
provincial and national policy makers and providers felt that microbicides would be perceived as 
beneficial if they were more “self-controlled” and “discreet” than existing products like the condom or 
female condom. A national policy maker stated unequivocally, “Definitely a contraceptive controlled by 
women themselves in an environment like here, no doubt there is a market.” Women felt that because 
women could apply microbicides themselves and potentially well in advance of either unanticipated or 
anticipated sexual activity, female consumers would find them attractive. Similarly, women felt that both 
men and women would find microbicides attractive because they offered a means of protection. In the 
words of one woman, “It’s better to use the gel: simply insert it and put aside.” One community member 
interviewed suggested it should be marketed as an “easier way to prevent infections.”   
 
Speaking more generally, however, a few women cautioned that the introduction of new products was 
sometimes met with suspicion in the community. New products were generally assumed to be “white 
man’s things” that would cause rather than prevent infections. Information and marketing would need to 
counter such rumors and myths. 
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As with any qualitative research, the findings of this study are not intended for generalization or to be 
viewed as representative of the perspectives and perceptions of any particular group or population, 
including the community of Langa. However, study data do echo and expand upon findings in previous 
social science research and programmatic experience in areas such as product characteristics, condoms 
and condom substitution, distribution strategies, and lubrication (“wetness”). Additionally, they have 
yielded several somewhat unexpected yet significant issues for consideration, such as the widespread 
understanding of women’s vulnerability and their need for products like microbicides, and the broad 
assumptions about microbicide use for protection in case of unplanned sex or rape. In this discussion 
section, we highlight a number of themes that have direct implications for policy or further research 
related to product development and introduction.   
 
Support for microbicides    
 
Until recently, microbicides were largely unknown as a potential HIV preventive, and questions existed 
about whether such an approach was scientifically or programmatically feasible. Consistent with the 
growing recognition of the potential of microbicides, respondents across the range of categories expressed 
strong support for product development and introduction. This interest derived from several related 
underlying issues that were described frankly and at times eloquently. 
 
First, participants exhibited widespread understanding and recognition of women’s social vulnerability to 
infection. Many spoke openly and spontaneously about the underlying social, economic, and political 
factors that contribute to women’s lack of control over sexual relations, and their concomitant 
vulnerability to HIV infection. Given the devastating impact of the HIV/AIDS epidemic in this setting, 
there was a real sense of desperation among community participants, providers, and policy makers for 
anything that could help stop the spread of HIV.  
 
Second, while respondents in all groups felt strongly that condoms must be promoted and supported, there 
was widespread recognition, and at times resignation, about the limitations of condoms that echo the 
findings of much previous research: people don’t use them, especially in primary partnerships; they 
interfere with intimacy and sexual pleasure; they prevent pregnancy; and so forth. Recognizing the 
limitations of current prevention strategies, there was a strong sense that additional prevention 
technologies and approaches are urgently needed, especially those that women can control. A number of 
policy makers and community members were already aware of microbicides due to ongoing research in 
South Africa, including a trial conducted in another part of Cape Town. However, few had a clear 
understanding of product approaches or indications, and a number had misconceptions about 
microbicides.   Given the devastating nature of the HIV/AIDS epidemic, there was an enormous sense of 
urgency and real frustration at the relatively long timeframe before an effective microbicide could 
potentially be made available.    
 
Despite some concerns, the need for microbicides and their potential resonated strongly with those 
interviewed for this study. This may be largely due to the level of the epidemic and vigorous public 
discourse on the issue. Strategies for developing support for microbicides will clearly need to be tailored 
to other contexts. Even with the significant support among those interviewed for this study, respondents 
expressed a number of concerns and uncertainties about microbicides, and an understandable need to 
know more about a specific product before they would approve, recommend, or use it. Therefore, while 
there seemed to be general support for a product like a microbicide, it is not clear whether such support 
for a hypothetical product would necessarily translate into practice. This also suggests that a more specific 
case will need to be built based on the evidence from research and characteristics of a particular product.  
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Implications of a partially effective product   
 
As expected, the issue of partial effectiveness emerged as a major concern, particularly among providers 
and policy makers. Microbicides were described to study participants as products under development, 
with the first generation of products expected to be partially effective, with a range estimated from 40–
70%. Initially, respondents across all three categories expressed some unease about the implications of 
introducing microbicides as a “stand-alone” product, given that they will be less effective than condoms. 
When considering how to introduce microbicides into existing prevention programs, many were more 
comfortable with microbicides as a “complement” or “addition” to existing prevention options. However, 
in a number of instances, after considering women’s vulnerability, their limited choices, the reality that 
people often can’t or don’t use condoms, and the urgent need for more prevention strategies, many 
recognized that even a partially effective method could be an important part of the overall HIV prevention 
effort.   
 
A few providers, in particular, questioned whether introducing a product less effective than condoms 
would be ethical, especially if it encouraged people to switch from using condoms, and expressed concern 
about their own ethical and legal liability if a person using such a product became infected with HIV. In 
general, providers and policy makers accepted that such products would be introduced in the context of 
other prevention methods, and might be recommended for use with condoms. While some questioned the 
practical feasibility of encouraging such dual-method use, there seemed to be a much greater comfort 
level with including microbicides as part of a hierarchy or method mix so that people would be able to 
choose from more options. Several providers expressed their own frustration at continually 
recommending that clients use condoms, knowing that many choose not to or are not able to, and that 
there is little else to offer them.   
 
Providers’ and policy makers’ concerns about partial effectiveness evolved from initial apprehension 
about practical and ethical implications, to a more positive and affirmative view of the role microbicides 
could play in reducing individual risk and population-based incidence.  In many cases, this evolution in 
thinking occurred during the course of the interview without prompting or intervention on the part of the 
interviewer. This underscores some of the complexities of resistance to microbicides and suggests that 
some initial concerns and assumptions may be amenable to change.     
 
The varied ways in which partial effectiveness was understood and discussed in relation to risk across all 
respondent categories underscored the challenges in accurately conveying complex messages about risk 
reduction and the options presented by a partially protective product. Other studies that have examined 
risk behavior, HIV, and condom use suggest that risk perception is highly specific to individual 
circumstances. This suggests the need for further targeted research on specific understanding and 
assessment of risk, practical approaches to conveying concepts of partial effectiveness, and implications 
of both for microbicide introduction.     
 
Condoms and condom substitution  
 
Policy and provider-level respondents expressed some concern about the possibility that people may 
switch from condoms to microbicides; thus, introducing microbicides would undermine condom 
promotion and use. Some community members confirmed this possibility, indicating that they would 
welcome the availability of microbicides primarily because they would provide an alternative to condoms. 
Ironically, several women participants and providers also suggested that microbicides could actually 
decrease women’s ability to negotiate condom use and thus increase their risk if partners insisted on 
microbicides instead of condoms. There was little discussion about people’s perceptions or assumptions 
about the particular circumstances and types of relationships in which condoms or microbicides would be 
used. Given our growing understanding about how relationships and other circumstances influence 
condom use, it would be useful to explicitly explore these themes with respect to microbicides.     
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Policy makers and providers sought to balance their concerns about condom substitution with 
acknowledgment of the realities of condom use. They reflexively positioned condoms as the “gold 
standard,” although on further reflection most acknowledged the condom’s limitations. They were 
particularly concerned about the implications of condom substitution for adolescents, who were perceived 
as at high risk and as having made some progress with using condoms. Findings suggest that while it is 
critical to continue to promote condoms and develop supportive strategies, it is also important to develop 
policy approaches and messages around introducing microbicides that accurately reflect actual levels of 
condom use and the impact that condoms have on risk reduction, rather than a theoretical ideal. In 
addition, concerns about condom substitution will likely shift with any changes in patterns of condom use 
that may occur. For example, if condom use increases, condom substitution will likely become more of a 
concern. Given the long timeframe for microbicide development and introduction, this issue will need to 
be continually revisited. 
 
Rape and unplanned consensual sex  
 
One of the primary unexpected findings was the degree to which respondents across levels, but 
particularly community members, assumed that an important application for microbicides would be use 
by women to provide protection if they were raped. This issue arose consistently and spontaneously in all 
respondent groups except providers. Rape is widespread in South Africa and has been extensively 
discussed and debated in the public arena. Both these factors have contributed to an acute awareness and 
perception among many South Africans that rape constitutes a very immediate risk in women’s daily 
lives. Women also discussed the utility of microbicides in the case of unplanned consensual sex. Both of 
these uses imply an assumption that women would be able to apply a microbicide as part of a daily 
routine. 
 
These findings have several concrete implications for microbicide development and introduction. This 
kind of application would necessitate that a microbicide has a relatively long duration of action, and that it 
would be both affordable and convenient enough to be used daily or even more frequently. While it is 
uncertain whether products could meet these expectations, it is encouraging in that people seemed willing 
to use microbicides or assumed that they could use microbicides on a routine basis. This also has 
implications for how microbicides could be introduced or marketed. While it is unlikely that any 
marketing strategy would focus on the risk of rape or sexual violence, these findings suggest an 
opportunity for building on the security of feeling protected “just in case.”  
 
Wetness, lubrication, and intravaginal practices 
 
The issue of “wetness” resonated strongly with study respondents as a serious concern and arose 
spontaneously within discussions on a range of topics. It has been an ongoing concern in the microbicide 
field that the lubricating properties of current gel formulations could compromise widespread use of 
microbicides. In this study, wetness had primarily negative associations with infidelity, lack of sexual 
pleasure for men, or STIs.  In some cases it was also recognized as associated with women’s sexual 
response and as something that women would welcome. Respondents across categories had quite different 
perceptions about how important added lubrication might be in hampering microbicide acceptability and 
use. The lively discussions and wide-ranging interpretations of lubrication underscore the need to 
examine the actual meanings associated with wetness and lubrication in different settings rather than 
relying on assumptions about practices or preferences  
 
Similarly, it is important to examine actual experience with respect to intravaginal product use and other 
intravaginal practices. Some policy makers thought that women would be uncomfortable with inserting a 
product vaginally. However, most women were quite familiar with using products intravaginally, 
especially for common RTIs, and spoke frankly about using vaginal creams and tampons. Beliefs and 
assertions by policy makers that “women won’t use them” because they are inserted vaginally could 
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erroneously inhibit support for microbicide introduction even in settings where such products are used 
regularly. 
 
Product characteristics   
 
Findings from this study confirm and further define preferences for microbicide product characteristics 
that have been suggested elsewhere. For example, while most respondents acknowledged that HIV is the 
most urgent concern, there was a strong preference for a product that is effective against a range of STIs. 
This was expressed particularly strongly by providers and likely reflects the significant burden that STIs 
impose on individuals and the health system in this community. While some respondents felt that a 
product that provides dual protection against pregnancy and HIV would be most convenient and 
appealing, many felt strongly that a non-contraceptive microbicide was more important. Several 
eloquently described the terrible dilemma faced by women and couples who want to, or need to, conceive 
but do not want to risk HIV infection. It is important to recognize that perceptions regarding contraceptive 
versus non-contraceptive properties are likely to vary where contraceptive prevalence is low, unlike South 
Africa. 
 
Many respondents assumed that microbicides would remain effective for long periods after insertion.  
These assumptions emerged most dramatically in the context of rape (described above) but also surfaced 
in comments about the product being used as part of a daily routine, like a deodorant. Wetness and 
lubrication were major topics of discussion, among all respondent groups, as described above. People 
spoke openly and creatively about the importance of developing products with different smells, tastes, and 
packaging and marketing approaches to appeal to a wide range of users. This further underscores the need 




Findings from this study suggest that microbicides could be positioned for a wide range of potential users.   
While in other settings people often assume that high-risk groups, particularly sex workers, would be the 
most likely and appropriate users for microbicides, respondents in this study cited a much wider range of 
potential user groups, and only providers discussed “high-risk groups,” including sex workers. First, it 
was nearly universally assumed that younger, unmarried women, including youth, would be important 
users of microbicides. However, while this was strongly supported by providers and community 
members, policy makers were less supportive of youth being targeted due to concerns that it would 
increase youth’s risk and potentially undermine recent gains in condom use. Reflecting widespread 
concern about child rape, a number of people also suggested that microbicides could offer protection for 
children who are at risk of sexual violence and rape. Another category identified was “older” married 
women who are still sexually active with their husbands from time to time. The idea of HIV-positive 
people using microbicides was raised, although not explored thoroughly. The possibilities for HIV-
positive people using such products to prevent secondary transmission, to prevent re-infection, or to 
prevent other STIs are additional areas for further exploration. 
 
One of the more interesting and encouraging elements throughout these discussions was the sense that 
microbicides would be “mainstream” products. Even sex workers themselves discussed microbicides in 
the context of mainstream use rather than in the context of sex work, possibly because sex workers are 
already using condoms somewhat successfully and the need is greater for single or married women who 
have difficulty negotiating condom use. There was little stigma that seemed to be associated with 
microbicides or with the women who might use them. The overall tenor of the discussions and specific 
suggestions about potential user groups suggested very pragmatic and non-judgmental analysis of the risk 
of HIV infection and the real obstacles women face in protecting themselves.     
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Positioning and distribution strategies 
 
Suggested distribution strategies underscored the tension between the need to maximize accessibility 
through making microbicides widely available in a range of clinical and non-clinical outlets, and the need 
to control distribution and provide counseling. Information and counseling were considered essential in 
order to convey complex messages about risk reduction and partial effectiveness and to assure fully 
informed choice. Community members noted that periodic supply shortages and erratic hours of operation 
in the public sector may make access to microbicides in the public sector difficult. They suggested a wide 
range of potential distribution points and strategies, including pharmacies, kiosks, and other shops where 
medicines and other consumer goods are sold. This was reinforced by several community leaders who 
cautioned against “medicalization” of the product and stressed the need to present products as appealing, 
fun and “normal.” However, policy makers, providers, and community members were all hesitant to 
endorse widespread distribution without adequate counseling or information. There was some support for 
a compromise approach in which products could be first introduced through a more formal clinical 
setting; once the public is familiar with the products’ attributes and has some experience using it, more 
widespread availability could be phased in over time.   
 
In general there was a strong sense that the best approach to positioning and marketing microbicides is to 
build on strong, affirmative messages that will associate the product with a healthy, dynamic, positive, 
and modern lifestyle.   
 
Raised expectations and ensuring supply  
 
A number of respondents in all categories underscored the importance of careful planning to balance 
creating demand with having the systems and infrastructure in place to meet it. Many people referred to 
the problems experienced with the female condom in South Africa, where introduction studies and efforts 
created demand for the product but the procurement and supply systems were initially not in place to 
adequately meet that demand. This example has important lessons for microbicide introduction.  
Damaging long-term effects can result if expectations are raised that cannot be met. This can undermine 
introduction and confidence in a product and in the health system as a whole.   
 
Because microbicides are a new product category, an accurate prediction of demand for the first 
microbicides in different settings will likely be very difficult. Given how urgently these products are 
needed, there will likely be pressure to produce and introduce them rapidly.    
 
Community members, and particularly providers and policy makers, had a strong “institutional memory” 
about lessons learned in different types of product introduction. This could potentially serve as a useful 
resource for considering how best to manage introduction of microbicides and other products. However, 
examples like the female condom may also make people cautious about embracing a new technology, 
particularly one that is so eagerly anticipated and urgently needed. 
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The recommendations presented below have been selected to draw attention to some of the less expected 
findings and to areas requiring careful analysis in other geographical, social, and epidemiological 
contexts. This study was conducted in only one community in South Africa for the community and 
service delivery levels of inquiry, and with provincial and national respondents for the policy level. The 
results are therefore not necessarily representative of South Africa or beyond, but instead are meant to 




“MAKING THE CASE” FOR MICROBICIDES 
 
" “Make the case” for microbicides based on specific setting: Further research in other 
geographical and epidemiological settings is needed to determine the best approach to “making 
the case” for microbicides. In this study, there appeared to be little need to convince people of the 
need for a product like microbicides. However, in the South African setting, the epidemic is at a 
very high level, and there has been a great deal of vibrant and open public discourse about 
HIV/AIDS, as well as some exposure to the concept of microbicides due to preparation for 
clinical trials. The broad recognition of the need for microbicides found in this study may not 
carry over to other settings where such issues are more hushed and stigmatized, where women’s 
vulnerability is not as well recognized, where public discourse about AIDS and microbicides is 
low or absent, and where cultural differences place greater restrictions on open discussion of 
sexual behaviors and practices.  
 
" Communicate the rationale: Efforts to evaluate the acceptability of microbicides on the 
provider and policy levels will require dialogue and probing beyond immediate responses. 
Likewise, efforts to communicate the rationale behind microbicides will require more than simple 
messages. Despite the broad support for microbicides among respondents in this study, initial 
responses were more mixed and muted. During the course of the discussions, some respondents 
who initially expressed concerns shifted to a positive sense of the need for microbicides.  
Opinions changed when people talked through the issues to arrive at their own conclusions, a 
finding that points to the value of qualitative research for a more in-depth exploration of issues.  
This suggests that initial perceptions and positions about the product may not be immutable, and 
that relying on initial responses may not yield a full consideration of the issue and a true response.  
These findings also suggest the need for advocacy and introduction strategies to assure adequate 
dialogue with individuals who are likely to support or inhibit introduction. 
 
" Understand how the “prevention equation” can be used: Further investigation will be needed 
to determine how the prevention equation is understood, and whether and how it could help make 
the case for microbicides. In this study, the prevention equation did not appear to be particularly 
important in convincing policy makers of the value of microbicides. It was explained to all 
providers and policy makers as part of the introduction to the interview, but received little 
reaction, possibly because it was not well explained, possibly because the importance of 
microbicides was already well-understood, or possibly because it simply was not an effective 
argument. However, this may differ in settings where the AIDS epidemic has not had as 
substantial an impact, and microbicides may not be as readily accepted or supported.    
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" Use information on intravaginal practices to counter erroneous assumptions: Introduction 
and advocacy efforts should take into account the fact that assertions or assumptions that women 
will not use intravaginal products may not hold true. In this study, notions expressed by policy 
makers about women being unfamiliar with or unwilling to use intravaginal products were not 
confirmed by providers and community members. In fact, many responded that women were 
quite accustomed to using vaginal products. Introduction and advocacy efforts may benefit from 
the use of local data about actual use of intravaginal products to counter erroneous assertions that 
could undermine introduction efforts.   
 
Developing Introduction Strategies 
 
" Balance broad access with the need for counseling and informed choice: The possibility of 
using distribution channels outside of the health sector, or outside of clinical service delivery, 
should be further explored in preparing for introduction. It will be important to determine how to 
balance interest in broad access with the need for careful counseling. Community respondents 
indicated interest in a wide range of distribution points, and also pointed to obstacles to accessing 
products in the public sector, including erratic hours of operation, constant shortages of supplies, 
and poor treatment by providers.   
 
" Address provider information and training needs: In order to assure support from health 
providers and their participation in introducing microbicides, introduction strategies must pay 
careful attention to providers’ information and training needs. Providers could be pivotal in 
influencing microbicide use. Providers indicated a need for in-depth information in order to feel 
comfortable recommending microbicides, including knowledge of side effects and results of 
clinical studies demonstrating effectiveness and safety. Providers want to be consulted and 
involved up-front, given that they are in the “front line” in distribution, counseling, and 
promotion. The issues surrounding microbicides are complicated, and providers will need training 
to develop the skills and comfort to effectively introduce the products, including the ability to 
articulate the advantages and disadvantages of microbicide use, to explain partial effectiveness, 
and to help clients communicate with partners. Although most providers in this study would 
likely support microbicides given adequate information, providers in other contexts may not be as 
receptive to such a product.  
 
" Market for use with or without a partner’s knowledge: Marketing and introduction strategies 
should take into account the need for both covert and overt use of microbicides. This study 
clearly demonstrated the desire by both women and men to communicate about microbicide use; 
however respondents also recognized the many circumstances that would require use without a 
partner’s knowledge, and they noted the benefits of having a method that could not be detected.  
Depending on actual product characteristics, covert use may be more or less feasible; marketing 
strategies could also influence the feasibility of covert use.     
 
" Consider youth as a potential target group  for microbicides: Youth need to be seriously 
considered in clinical studies, introduction strategies, and further research as a potential user 
group for microbicides. Young people were spontaneously, readily, and consistently identified in 
this study as among the primary potential users of microbicides, despite some strong reservations 
about possibly undermining recent gains in condom use. The results point to the need to develop 
strategies that actively facilitate access and use by youth in South Africa. In different settings, 
even with similar needs, young people’s access to sexual and reproductive health services may be 
more constrained and receptivity to them as a user group may be different. 
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" Ensure a balance of supply and demand:  It will be critical to assure that reliable supply and 
delivery systems are in place before demand is created; demand creation should be carefully 
balanced with supply limitations to avoid potential backlash against the product. This is 
particularly important during the critical and sensitive introduction and scale-up stages.   
Although in this study only a few respondents expressed concern about broad distrust of “the 
system,” where this is more widespread due to historical abuses or perceived manipulations, 
introducing a product and failing to meet supply needs could potentially exacerbate such distrust, 
which could slow or halt introduction efforts.   
 
" Enlist multisectoral support for introduction: Involving a broad range of sectors in the public 
domain as well as elements of civil society will be critical to assuring smooth introduction and 
should be taken into account in introduction strategies. Given the complicated nature of 
microbicides and concerns around partial effectiveness, enlisting the support of broad segments 
of society may be critical. Several policy makers, policy influentials, and community key 
informants in this study stressed the importance of enlisting the support of individuals and 
organizations inside and outside of the health sector. The support of community groups, churches, 
labor unions, and others may be essential to counter potential fear of the “unknown” that may 
come with the introduction of a new product. 
 
" Address diverse needs: It will be important to determine the possibilities for different 
microbicide products to meet diverse needs and to continually reassess these as new products 
with different characteristics become available. This research suggests interest in both free and 
low-cost products, the potential for use with or without a partner’s knowledge, and appeal to 
different user groups, including married or unmarried people, youth, and sex workers. It also 
suggests the need for use under varying circumstances, such as daily routine use in case of the 
unanticipated sex, and use in specific situations or with specific partners. Product characteristics 
such as contraceptive properties, effectiveness for use by HIV-positive people, and different 





" Use qualitative research to understand the complexities of perceptions about microbicides, 
and to allow new ideas to emerge: Further targeted, qualitative research designed to allow 
emergence of new ideas would be valuable to inform introduction strategies and to better 
understand the potential facilitating factors and barriers to microbicide introduction and use. In 
this research, effort was made to identify critical issues up-front based on previous research, 
review of the literature, and discourse in the microbicide field. Nevertheless, several important 
issues that had not been anticipated emerged from the research. For example, the prevalent notion 
of routine microbicide use as a response to the threat of rape or sexual coercion, the notion that 
microbicides would be useful to put in “before you go out” in case of unplanned sex, and the 
importance of youth as a primary user group all emerged quite strongly from the data.  
 
" Understand the meanings and implications of “wetness”: Further research is needed in South 
Africa and elsewhere to understand the implications for microbicide introduction of the notion of 
“wetness.” This study confirmed that “wetness” is a major concern in this setting, although the 
manner in which respondents understood wetness was quite nuanced and multifaceted (e.g., 
implications of infidelity, reduced sexual pleasure, STIs), and did not necessarily reflect “dry sex” 
that has been a concern in HIV-prevention efforts and discourse about microbicides. This study 
also confirmed that concerns related to lubrication and wetness are likely to be serious 
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considerations in community-level acceptability and use. Still, little is known about how or 
whether these same concerns would apply in other cultural and geographic settings, and their 
implications for product development, marketing strategies, and education and counseling 
approaches.   
 
" Investigate potential stigma associated with microbicides: It will be important to further 
investigate the implications of stigma for microbicide introduction strategies in diverse settings, 
particularly in considering distribution channels and marketing efforts. Although stigma against 
the product itself or against those who might need microbicides did not emerge in this research as 
a major issue, this may be quite different in other settings, particularly where discourse about 
HIV/AIDS is less open, or where the epidemic may be at a low enough level that it is not 
perceived as “affecting everyone.”  In addition, it will be important to further investigate any 
associations that may be made between Nonoxynol-9 and microbicides. While the issue did not 
receive significant attention in this research (in part due to the fact that spermicides are not 
generally used in South Africa), in other settings there may be still be some stigma associated 
with the entire class of products based on the results of the N-9 trials. 
 
" Develop approaches to explaining partial effectiveness: Further research will be needed to 
determine approaches to explaining the meanings and implications of partial effectiveness. Partial 
effectiveness was clearly a major concern among all groups interviewed. Study respondents 
varied widely in their understanding of the concept and in their understanding of concepts related 
to harm reduction. Determining approaches to explaining partial effectiveness for different 
audiences will be useful to ongoing research, advocacy, and ultimately introduction efforts. 
 
" Investigate the effectiveness and implications of microbicide use by HIV+ women: Given the 
growing population of HIV+ people in South Africa and elsewhere, further consideration needs to 
be given to the reproductive and other health needs of this group. This is particularly important in 
the context of more widespread availability of anti-retroviral treatment in South Africa and 
elsewhere and in the light of possible interactions between other contraceptive methods, such as 
hormonal contraceptives for women. 
 
 




The challenges facing microbicide introduction are complex, as the findings of this study demonstrate.  
Respondent views have clearly been influenced by the sense of urgency and desperation in face of the 
devastating impact of the HIV/AIDS epidemic in South Africa. This study has contributed to better 
understanding of barriers and facilitating factors likely to influence microbicide introduction in the South 
African context. For some issues, this has provided a more complete and nuanced understanding of how 
microbicides are perceived, and the nature of concerns around them. Others have newly emerged from 
this research.   
 
Some of the findings of this study were not surprising, as they reflect experience with other technologies 
and innovations, or common assertions that have been made in the discourse on microbicides and HIV.  
In these instances, study findings provide documentation and confirm these assertions. For example, this 
research confirmed the widespread concern about partial effectiveness, and the need to develop strategies 
for presenting and explaining this to diverse interest groups. It also confirmed the notion that assumptions 
about women’s experience with and attitudes about intravaginal product use do not necessarily reflect 
actual use and comfort with such products. In addition, the findings from this research project also 
highlighted the fact that recognition of the need for microbicides is strongly influenced by the context, 
particularly experience with the HIV/AIDS epidemic. 
 
Several findings from this study raised new issues and perspectives that have not been carefully 
examined, widely recognized, or discussed in the microbicides field. The most dramatic of these is the 
assumption that microbicides could be used on a routine basis to protect against infection in the case of 
rape or unplanned consensual sex. Other examples of new perspectives include the strong focus and 
complex issues associated with youth as among the primary users of microbicides; the assumption that 
microbicides would be a product for mainstream use by a range of different segments of the population; 
and the strong provider preference for a product that protects against a range of STIs, with less interest in 
pregnancy prevention. 
 
Some of the findings appear to be specific to the local context and may not necessarily reflect views in 
other epidemiological or sociocultural settings. For example, the apparent preference for non-
contraceptive properties among potential users and the lack of interest among providers in contraceptive 
properties may differ in settings where contraceptive prevalence and access to family planning services is 
lower. The strong desire for data and other evidence to prove safety and effectiveness may stem, in part, 
from the specific historical context. The fact that the prevention equation had little resonance, the broad 
recognition of the need for microbicides, and realistic assessment of the limitations of condoms may also 
differ significantly.    
 
Many of the issues examined in this research will require further investigation and consideration in other 
epidemiological and sociocultural settings. Some will prove to be broadly applicable, while others will be 
more specific to the local or national context. Successful and rapid introduction of microbicides, critical 
to providing women with a prevention approach they can control and to stemming the HIV/AIDS 
epidemic, will clearly require further research, advocacy, and careful preparation. 
 
Finally, an important limitation of this research is that the product that was described and shown to 
respondents is still hypothetical in terms of its physical properties, degree of effectiveness, side effects, 
and so forth. Therefore it is important to caution that perceptions and opinions—positive or negative— 
about these potential products should not be over interpreted. It is unclear whether the relatively 
enthusiastic responses to this hypothetical product would be borne out when confronted with a decision 
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about whether to approve, promote, or use an actual microbicide product. This is likely to be influenced 
by a complex calculus among the actual product’s characteristics, the nature of the sexual relationship, the 
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VII. APPENDIXES 
 
APPENDIX 1: Research sampling by respondent categories 
 
 FGD sessions 
(total participants) 
IDI Respondents 
   
Community Level   
 
Women 18-25 - Lower SES (Joe Slovo informal 
settlement) 
 
2 (20 participants) 
 
Women 26-45 - Lower SES (Joe Slovo informal 
settlement) 
2 (20 participants)  
Women 18-25 - Medium SES (Rented) 2 (19 participants)  
Women 26-45 - Medium SES (Rented) 3 (30 participants)  
Women 26-45 - Higher SES (Homeowners) 2 (20 participants)  
Men 18-25 - Lower SES 
(Joe Slovo informal settlement) 
1 (7 participants)  
Men 26-45 – Lower SES 
(Joe Slovo informal settlement) 
1 (10 participants)  
Men 18-25 - Medium SES (Rented) 1 (10 participants)  
Men 26-45 – Medium SES (Rented) 1 (10 participants)  
Men 26-45 – Higher SES (Homeowners) 2 (18 participants)  
Female Taverners 1 (10 participants)  
Female Sex Workers 1 (10 participants)  
Male Taverners 2 (20 participants)  
Women & Men (teachers) 1 (9 participants)  
Community Key Informants  11 
   
Service Delivery Level 
 
  
Public Health Practitioners  3 
Private Practitioners  2 
Public Health Managers  2 
Nurses 1 (5 participants)  




National Policy Influentials  3 
Provincial Key Policy Influentials  6 
Media  1 
Professional Bodies  1 
TOTAL 23 (218 participants) 38 
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APPENDIX 2: Socio-demographic characteristics of community  
focus group participants 
 





Mean age (standard deviation) 
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* Indicates missing data.
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APPENDIX 3: Key issues explored by respondent level 
 
 
Illustrative Key Issues Across All Levels (Community, Service, and Policy) 
 
" General perspectives on the concept of microbicides—reasons for support, potential barriers 
to introduction and use 
" Perceived need for, and ability to use, a woman-controlled method for HIV/STI prevention 
" Concepts of harm reduction and partial effectiveness; how concepts are understood, 
perceived, accepted, and best explained; also dual method use (condom and microbicides) 
and dual protection? 
" Perceptions of product benefits and attributes for positioning/marketing  
" Potential avenues/venues for introduction, education and distribution—e.g. public and private 
health services, pharmacies, community outlets (shops and community based health 
workers/distributors) 
" Key areas of information/understanding that would influence recommendations for 
microbicide use or advocacy for products, or product use  
" Norms, values, and behaviors associated with sexuality and accessing technologies to prevent 
HIV/STIs  
 
Issues for Policy Level of Inquiry 
 
" Attitudes to introducing/importing a method that is only partially effective  
" Understanding of the “prevention equation” —the potential population-level impact and 
public health benefit of a lower efficacy method if it is more acceptable and therefore used 
more consistently  
" Potential concerns about  “condom migration”  (i.e. microbicide use replacing condom use) 
" Clinical testing/results—Conditions/knowledge necessary for promoting product (e.g. local 
safety or effectiveness testing) 
" Constituencies that could facilitate introduction 
 
Issues for Health Service Delivery Level of Inquiry 
 
" Experiences with the introduction of other new technologies 
" Perceptions of who should and who would use 
" The hierarchy of methods: willingness to offer a less efficacious method when clients 
perceive more efficacious methods as feasible 
" Ways of communicating hierarchy of methods to clients 
" Information needed by clients prior to being provided with product 
" Informed choice for HIV prevention methods: provider inclination/bias re recommendations 
" Perceptions of user-controlled and/or less efficacious methods 
" Awareness and perceptions of clients’ intravaginal and sexual practices  
" Perceptions of clients’ willingness to use microbicides  
" Understanding of gender/power dynamics limiting condom use  
" Understanding implications of gender/power dynamics for microbicide use 
" Optimal channels for information, counseling and product distribution 
" Concerns about microbicide use replacing condom use (“condom migration”)  
" Providers’ attitudes toward discussing sexuality openly and in-depth with clients 
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Issues for Community Level of Inquiry 
 
" Implications of local sexual and intravaginal practices for potential microbicide use 
" Perceptions of who might use such a product 
" Preferences for male involvement versus covert use 
" Perception of partner attitude towards use 
" Perceptions of potential impact on sexual pleasure 
" Practices related to spermicide use/perceptions of spermicides 
" Product characteristic preferences (e.g. lubrication, spermicidal vs. non-spermicidal) 
" Potential local advocates  
" Willingness to use, based on various levels of efficacy 
" Perception of health services and non-health sectors for potential information, counseling and 
product distribution 
" Potential for association of the product only with illicit sex; stigma (e.g. condoms and 
commercial sex workers) 
" Information needed to make informed choice 
" Community involvement for introduction/distribution 
" Influentials/opinion leaders who influence norms, values, and behaviors related to sexuality 
and health 
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